Processing 00000000.tx.1: Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35 IMPLICATIONS FOR ALZHEIMER'S DISEASE* Flix Hernndez, Mar Prez, Jos J. 

Phrase: "Glycogen Synthase Kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a Crucial Role in Tau Exon 10 Splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "Intranuclear Distribution of SC35 IMPLICATIONS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "FOR ALZHEIMER'S DISEASE"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0002395:Alzheimer's Disease [Disease or Syndrome]
   913   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "* Flix Hernndez,"

Phrase: "Mar"

Phrase: "Prez,"

Phrase: "Jos J."
Processing 00000000.tx.2: Lucas, Ana M. 

Phrase: "Lucas,"

Phrase: "Ana M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Mata, Ratan Bhat, and Jess Avila|| From the Centro de Biologa Molecular "Severo Ochoa" Consejo Superior de Investigaciones Cientficas/CSIC/Universidad Autnoma, Fac. 

Phrase: "Mata,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "Ratan Bhat,"

Phrase: "and"

Phrase: "Jess Avila||"

Phrase: "From the Centro de Biologa Molecular ""Severo Ochoa"" Consejo Superior de Investigaciones Cientficas/CSIC/Universidad Autnoma,"

Phrase: "Fac."
Processing 00000000.tx.4: Ciencias. 

Phrase: "Ciencias."
Processing 00000000.tx.5: Universidad Autnoma de Madrid, Cantoblanco, 28049 Madrid, Spain and AstraZeneca R & D, Sdertlje, SE-151 85 Sweden Received for publication, October 21, 2003 , and in revised form, November 5, 2003.  

Phrase: "Universidad Autnoma de Madrid,"

Phrase: "Cantoblanco,"

Phrase: "28049 Madrid,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "AstraZeneca R & D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Sdertlje,"

Phrase: "SE-151 85 Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038995:Sweden [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 21,"

Phrase: "2003 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "November 5,"

Phrase: "2003."
Processing 00000000.tx.6: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Tauopathies, including Alzheimer's disease, are neurodegenerative disorders in which tau protein accumulates as a consequence of alterations in its metabolism. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tauopathies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "neurodegenerative disorders in which tau protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   790   C1522560:Neurodegenerative Disorders [Functional Concept]
   753   C0012634:Disorders [Disease or Syndrome]

Phrase: "accumulates as a consequence of alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0686907:Consequence of [Functional Concept]
           Consequence
   719   C1515926:Alteration [Idea or Concept]

Phrase: "in its metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.7: At least three different types of alterations have been described; 

Phrase: "At least three different types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0332307:Types [Qualitative Concept]
   779 E C1547052:*Type [Quantitative Concept]

Phrase: "of alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.8: in some cases, an aberrant mRNA splicing of tau exon 10 occurs; 

Phrase: "in some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "an aberrant mRNA splicing of tau exon 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086934:mRNA splicing [Genetic Function]
   744   C0035687:Splicing [Genetic Function]
   744   C2610186:splicing [Genetic Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.9: in other cases, the disorder is a consequence of missense mutations and, in most cases, aberrant tau hyperphosphorylation takes place. 

Phrase: "in other cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "is"

Phrase: "a consequence of missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "and"

Phrase: ","

Phrase: "in most cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "aberrant tau hyperphosphorylation"

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.10: Glycogen synthase kinase-3 (GSK-3) has emerged as a key kinase that is able to interact with several proteins involved in the ethiology of Alzheimer's disease and other tauopathies. 

Phrase: "Glycogen synthase kinase-3 (GSK-3)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "emerged as a key kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "interact with several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in the ethiology of Alzheimer's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1314792:disease etiology [Functional Concept]
           Aetiology
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015127:aetiology [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "other tauopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]
Processing 00000000.tx.11: Here, we have evaluated whether GSK-3 is also able to modulate tau-mRNA splicing. 

Phrase: "Here,"

Phrase: "we"

Phrase: "have"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether"

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "also able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "tau-mRNA splicing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086934:mRNA splicing [Genetic Function]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]
Processing 00000000.tx.12: Our data demonstrate that GSK-3 inhibition in cultured neurons affects tau splicing resulting in an increase in tau mRNA containing exon 10. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that GSK-3 inhibition in cultured neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
   720   C0234074:Neuronal inhibition [Organ or Tissue Function]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "tau splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "resulting in an increase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in tau mRNA containing exon 10."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0332256:Containing [Functional Concept]
   804   C1720655:Tau [Intellectual Product]
   804   C1947974:Tau [Research Activity]
   804   C2700400:Containing [Activity]
Processing 00000000.tx.13: Pre-mRNA splicing is catalyzed by a multimolecular complex including members of the serine/arginine-rich (SR) family of splicing factors. 

Phrase: "Pre-mRNA splicing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1622990:pre-mRNA splicing [Genetic Function]
   901   C0086934:mRNA splicing [Genetic Function]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]
   734   C0026661:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "catalyzed by a multimolecular complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "members of the serine/arginine-rich (SR) family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "of splicing factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.14: Immunofluorescence studies showed that after GSK-3 inhibition, SC35, a member of the SR family, is redistributed and enriched in nuclear speckles and colocalizes with the kinase. 

Phrase: "Immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "after"

Phrase: "GSK-3 inhibition,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "SC35,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "a member of the SR family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "is"

Phrase: "redistributed"

Phrase: "and"

Phrase: "enriched in nuclear speckles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1750270:nuclear speckles [Cell Component]
   770   C0359583:enriched [Food]
   770   C0521447:Nuclear [Spatial Concept]

Phrase: "and"

Phrase: "colocalizes with the kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.15: Furthermore, immunoprecipitated SC35 is phosphorylated by recombinant GSK-3. 

Phrase: "Furthermore,"

Phrase: "immunoprecipitated SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419992:SC35 [Gene or Genome]
   861   C3538863:SC35 [Gene or Genome]

Phrase: "is"

Phrase: "phosphorylated by recombinant GSK-3."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1514798:recombinant [Organism]
Processing 00000000.tx.16: Phosphorylation of a peptide from the SR domain by GSK-3 revealed that the peptide needs to be prephosphorylated, suggesting the involvement of a priming kinase. 

Phrase: "Phosphorylation of a peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "from the SR domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "prephosphorylated"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the involvement of a priming kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.17: Our results demonstrate that GSK-3 plays a crucial role in tau exon 10 splicing, raising the possibility that GSK3 could contribute to tauopathies via aberrant tau splicing.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a crucial role in tau exon 10 splicing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "contribute to tauopathies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0949664:Tauopathies [Disease or Syndrome]
   790   C1880177:Contribute [Activity]

Phrase: "via aberrant tau splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]
Processing 00000000.tx.18: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Tau is a brain microtubule-associated protein that promotes microtubule stability (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a brain microtubule-associated protein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "microtubule stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: Tau plays a key role in the morphogenesis of neurons, and to a lesser extent, the morphogenesis of glial cells, where it is also present at low levels (3). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a key role in the morphogenesis of neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and to a lesser extent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "the morphogenesis of glial cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1156238:cell morphogenesis [Cell Function]
   760   C0026559:Morphogenesis [Organism Function]

Phrase: "where"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "present at low levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0150312:Present [Quantitative Concept]
   770   C0205251:low [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: The human tau gene contains 16 exons from which different tau isoforms are generated by alternative splicing (4, 5). 

Phrase: "The human tau gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0314604:Human gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "16 exons from which different tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "generated by alternative splicing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0002345:Alternative Splicing [Genetic Function]
   770   C0035687:Splicing [Genetic Function]
   770   C1523987:Alternative [Conceptual Entity]
   770   C2610186:splicing [Genetic Function]
   770   C3146294:Generated [Activity]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: Some of these isoforms are selectively expressed during embryonic and early postnatal development (5-7), whereas in the adult central nervous system, six different tau isoforms are expressed that differ in the presence or absence of exons 2, 3, and 10 (8). 

Phrase: "Some of these isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   770   C3540770:Some [Intellectual Product]

Phrase: "are"

Phrase: "selectively"

Phrase: "expressed during embryonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013935:Embryonic [Embryonic Structure]

Phrase: "and"

Phrase: "early postnatal development"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C1135598:postnatal development [Organism Function]
   827   C0243107:development [Physiologic Function]
   827   C0443281:Postnatal [Temporal Concept]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "(5-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas in the adult central nervous system,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0927232:Central Nervous System [Body System]
   814   C1269563:Central nervous system [Body System]
   778   C0027763:Nervous System [Body System]
   778   C0422837:NERVOUS SYSTEM [Finding]
   778   C1269560:Nervous system [Body System]
   748   C0001675:Adult [Age Group]
   748   C0027769:Nervous [Sign or Symptom]
   748   C0205099:Central [Spatial Concept]
   748   C0449913:System [Functional Concept]
   748   C0599851:Nervous [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1706450:Adult [Human]
   748   C1879652:Central - [Laboratory Procedure]
   723 E C0205494:Neurologic [Qualitative Concept]

Phrase: "six different tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "expressed"

Phrase: "that"

Phrase: "differ in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of exons 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "10"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.22: Exon 10 encodes one of the four repeat sequences (8, 9) that form the microtubule-binding domain (8, 10). 

Phrase: "Exon 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "one of the four repeat sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the microtubule-binding domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1149274:microtubule binding [Molecular Function]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(8,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.23: The presence of exon 10 results in tau with four repeat microtubule-binding sequences (4R), whereas the alternatively spliced isoforms without exon 10 have only three of these sequences (3R). 

Phrase: "The presence of exon 10 results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "with four repeat microtubule-binding sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "(4R"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the alternatively spliced isoforms without exon 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "only three of these sequences"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0205171:Only [Quantitative Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "(3R"

Phrase: ")."
Processing 00000000.tx.24: A group of neurodegenerative disorders is referred to as tauopathies because tau protein is assembled into aberrant aggregates in the brains of affected individuals (11). 

Phrase: "A group of neurodegenerative disorders"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0441835:a group [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "because"

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "assembled into aberrant aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205418:aggregates [Qualitative Concept]
   770   C0443127:Aberrant [Qualitative Concept]
   737   C1706853:Assemble [Activity]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of affected individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.25: One of these tauopathies, frontotemporal dementia with parkinsonism associated to chromosome 17 (FTDP-17),1 is an inherited dementia that occurs as a consequence of tau mutations in both coding and non-coding regions (12-14). 

Phrase: "One of these tauopathies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "frontotemporal dementia with parkinsonism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   909   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   833   C0236642:frontotemporal dementia [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "associated to chromosome 17"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   770   C0332281:Associated [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "is"

Phrase: "an inherited dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "that"

Phrase: "occurs as a consequence of tau mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0686907:Consequence of [Functional Concept]
           Consequence
   748   C0026882:Mutations [Genetic Function]
   748   C1709305:Occur [Activity]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C2745955:OCCUR [Temporal Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in both coding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009219:Coding [Occupational Activity]

Phrase: "and"

Phrase: "non-coding regions"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0079941:Coding Region [Gene or Genome]
   827   C0009219:Coding [Occupational Activity]
   827   C1518422:Non [Functional Concept]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   793 E C0805701:Code [Intellectual Product]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(12-14"

Phrase: ")."
Processing 00000000.tx.26: Most exonic mutations are single amino acid substitutions that result in the reduced ability of tau to interact with microtubules (8, 9). 

Phrase: "Most exonic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "single amino acid substitutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   779   C1555721:Substitution [Idea or Concept]
   779   C1706204:Substitution [Activity]

Phrase: "that"

Phrase: "result in the reduced ability of tau to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0085732:Ability [Organism Attribute]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]
   744   C2825142:Result [Finding]

Phrase: "interact with microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026046:Microtubules [Cell Component]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.27: On the other hand, some exonic and virtually all the intronic FTDP-17 tau mutations affect RNA processing, resulting in an increase in tau 4R isoforms (8, 12-20) with the only exception being the exonic A280K mutation that results in a decrease in tau 4R isoforms (15-21). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "some exonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "virtually"

Phrase: "all the intronic FTDP-17 tau mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   881   C1881250:Intronic Mutation [Genetic Function]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "RNA processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158728:RNA Processing [Genetic Function]
   861   C1709694:Processing [Activity]

Phrase: "resulting in an increase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in tau 4R isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(8,"

Phrase: "12-20"

Phrase: ")"

Phrase: "with the only exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "being"

Phrase: "the exonic A280K mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that results in a decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in tau 4R isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(15-21"

Phrase: ")."
Processing 00000000.tx.28: Thus, alteration in the tau 4R/tau 3R proportion of isoforms is sufficient to trigger neurodegeneration in frontotemporal dementia, and probably, this might also play a role in other neurodegenerative disorders such as progressive nuclear palsy or corticobasal degeneration, which are characterized by an increase in tau 4R isoforms (11). 

Phrase: "Thus,"

Phrase: "alteration in the tau 4R/tau 3R proportion of isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1515926:Alteration [Idea or Concept]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "neurodegeneration in frontotemporal dementia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "probably,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "this"

Phrase: "might"

Phrase: "also"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in other neurodegenerative disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "such as progressive nuclear palsy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0522224:Palsy [Finding]

Phrase: "or"

Phrase: "corticobasal degeneration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "which"

Phrase: "are"

Phrase: "characterized by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1880022:Characterized [Activity]

Phrase: "in tau 4R isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.29: Thus, gaining insight to the regulation of alternative splicing of human tau exon 10 has been of critical interest (15, 22). 

Phrase: "Thus,"

Phrase: "gaining"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   966   C1517378:Gain [Quantitative Concept]
   928 E C0205217:Increased [Quantitative Concept]
   928 E C0439661:Acquired [Temporal Concept]
   928 E C0442805:Increase [Functional Concept]
   928 E C0442808:Increasing [Functional Concept]
   928 E C1301820:Obtain [Functional Concept]
   928 E C1706701:Acquire [Activity]
   928 E C3245488:acquired [Intellectual Product]

Phrase: "insight to the regulation of alternative splicing of human tau exon 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0233820:Insight [Mental Process]

Phrase: "has"

Phrase: "been of critical interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C1511545:Critical [Qualitative Concept]

Phrase: "(15,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.30: RNA splicing is a complex mechanism wherein five different small nuclear ribonucleoproteins, components of the spliceosome, play a role together with other factors (23, 24). 

Phrase: "RNA splicing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035687:RNA Splicing [Genetic Function]
           Splicing
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "a complex mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "wherein"

Phrase: "five different small nuclear ribonucleoproteins,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C0142661:Small Nuclear Ribonucleoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   851 E C1167162:small nuclear ribonucleoprotein [Cell Component]
   804   C0035544:Ribonucleoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0700321:Small [Quantitative Concept]
   771 E C1167298:ribonucleoprotein [Cell Component]

Phrase: "components of the spliceosome,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role together with other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.31: Among these other factors are a family of proteins called SR proteins because they contain an arginine- and serine-rich domain in their C-terminal portion that influences the selection of alternative splicing sites (25, 26). 

Phrase: "Among these"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "a family of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "SR proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "because"

Phrase: "they"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an arginine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "serine-rich domain in their C-terminal portion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "influences"

Phrase: "the selection of alternative splicing sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   798   C1327242:splice site selection [Genetic Function]
   798   C1327244:splice site selection [Genetic Function]
   753   C0036576:selection [Genetic Function]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.32: Glycogen synthase kinase (GSK-3) has emerged as a key kinase that is able to interact with many of the proteins involved in the etiology of Alzheimer's disease (AD), the most common of tauopathies, as well as other tauopathies (27). 

Phrase: "Glycogen synthase kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "has"

Phrase: "emerged as a key kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "interact with many of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in the etiology of Alzheimer's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1314792:disease etiology [Functional Concept]
           Aetiology
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015127:aetiology [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1524003:Etiology [Conceptual Entity]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "the most common of tauopathies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "as well as"

Phrase: "other tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.33: GSK-3 is a serine/threonine kinase originally identified due to its role in glycogen metabolism regulation and which is most abundant in the central nervous system (28). 

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a serine/threonine kinase originally"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   923   C1414387:serine/threonine kinase [Gene or Genome]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "identified due to its role"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0035820:Role [Social Behavior]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1705810:Role [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "in glycogen metabolism regulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159402:metabolism regulation [Organism Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0599784:glycogen metabolism [Molecular Function]

Phrase: "and"

Phrase: "which"

Phrase: "is"

Phrase: "most abundant in the central nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346714:Abundant [Qualitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.34: GSK-3 accumulates in the cytoplasm of AD pretangle neurons and in tau deposits in most tauopathies (29), and its distribution in brains staged for AD neurofibrillary changes is coincident with the sequence of development of these changes (30, 31). 

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "accumulates in the cytoplasm of AD pretangle neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C1178979:Cytoplasm of neuron [Cell Component]
           Neuron cytoplasm
   744   C0010834:Cytoplasm [Cell Component]
   744   C0027882:Neurons [Cell]

Phrase: "and in tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1515981:And [Idea or Concept]
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "deposits in most tauopathies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333562:Deposit [Functional Concept]
   770   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "its distribution in brains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "staged for AD neurofibrillary changes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0679846:change stage [Intellectual Product]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726   C0205390:Stage [Temporal Concept]
   726   C1300072:Stage [Clinical Attribute]
   726   C1306673:Stage [Qualitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "coincident with the sequence of development of these changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205420:Coincident [Temporal Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.35: GSK-3 has been shown to phosphorylate tau in most sites hyperphosphorylated in AD-tau in transfected cells (32). 

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "tau in most sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "hyperphosphorylated in AD-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.36: Overexpression of GSK-3 in the brain of conditional transgenic mice resulted in tau hyperphosphorylation and somatodendritic localization of tau (33). 

Phrase: "Overexpression of GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514559:Overexpression [Genetic Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of conditional transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "resulted in tau hyperphosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "and"

Phrase: "somatodendritic localization of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.37: Furthermore, -amyloid toxicity has been shown to be mediated by an increase in GSK-3 activity (34, 35). 

Phrase: "Furthermore, -"

Phrase: "amyloid toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mediated by an increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0442805:Increase [Functional Concept]

Phrase: "in GSK-3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.38: All these data point toward GSK-3 as a key enzyme in regulating tau metabolism. 

Phrase: "All"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "point toward GSK-3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1552961:Point [Quantitative Concept]
   753   C2347617:point [Quantitative Concept]

Phrase: "as a key enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "in"

Phrase: "regulating"

Phrase: "tau metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.39: Here, we have studied whether GSK-3 activity, apart from affecting tau phosphorylation, also affects the regulation of alternative splicing of tau exon 10, the other main alteration found in tau metabolism in neurodegenerative disorders.  

Phrase: "Here,"

Phrase: "we"

Phrase: "have"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "whether"

Phrase: "GSK-3 activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "apart from affecting tau phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "also"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the regulation of alternative splicing of tau exon 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "the"

Phrase: "other main alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1515926:Alteration [Idea or Concept]

Phrase: "found in tau metabolism"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C0150312:Found [Quantitative Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737 E C0243095:Find [Finding]

Phrase: "in neurodegenerative disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.40: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  AntibodiesThe following antibodies were used: according to the residue numbering of the longest human tau isoform of 441 amino acids, antibody PHF-1 (a gift from Dr. Peter Davies) recognizes tau protein when serines 396 and 404 are phosphorylated. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "AntibodiesThe"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "according to the residue numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449788:numbering [Quantitative Concept]
   827 E C0237753:*Number [Quantitative Concept]

Phrase: "of the longest human tau isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "of 441 amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "antibody PHF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "a gift from Dr. Peter Davies"

Phrase: ")"

Phrase: "recognizes"

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "when"

Phrase: "serines 396"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "404"

Phrase: "are"

Phrase: "phosphorylated."
Processing 00000000.tx.41: Sources of commercial antibodies were: anti-GSK-3 (Transduction Laboratories), anti-GSK-3/(pY279/216) (BioSource), anti-SC35 (Sigma), and anti--tubulin (Sigma). 

Phrase: "Sources of commercial antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C0449424:Source of antibody [Finding]
   819   C1516719:Commercial Sources [Classification]
   770   C0449416:sources [Finding]
   737 E C1705919:Source [Idea or Concept]

Phrase: "were"

Phrase: ":"

Phrase: "anti-GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Transduction Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-GSK-3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(pY279/216"

Phrase: ")"

Phrase: "(BioSource"

Phrase: ")"

Phrase: ","

Phrase: "anti-SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419992:SC35 [Gene or Genome]
   861   C3538863:SC35 [Gene or Genome]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: Primary CulturePrimary cultures of cortical neurons were prepared according to modifications of established procedures (36). 

Phrase: "Primary CulturePrimary"

Phrase: "cultures of cortical neurons"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0001613:Cortical [Body Part, Organ, or Organ Component]
   770   C0007776:Cortical [Body Part, Organ, or Organ Component]
   770   C0010453:Culture [Idea or Concept]
   770   C0022655:Cortical [Body Part, Organ, or Organ Component]
   770   C0027882:Neurons [Cell]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C2242979:Culture [Laboratory Procedure]
   715 E C0234875:bark [Organism Attribute]
   715 E C2700441:Bark [Plant]

Phrase: "were"

Phrase: "prepared according to modifications of established procedures"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   748   C0025664:procedures [Intellectual Product]
   748   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   748   C0443211:Established [Qualitative Concept]
   748   C0680240:according [Social Behavior]
   748   C1272684:Established [Qualitative Concept]
   748   C2700391:procedures [Activity]
   714   C0392747:Modification [Functional Concept]
   714   C1521827:Prepare [Functional Concept]
   714   C1554963:modification [Qualitative Concept]
   714 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   714 E C3274430:PROCEDURE [Health Care Activity]
   714 E C3538935:Procedure [Idea or Concept]
   714 E C3539779:Procedure [Intellectual Product]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.43: Briefly, pups were sacrificed at postnatal day 1. 

Phrase: "Briefly,"

Phrase: "pups"

Phrase: "were"

Phrase: "sacrificed at postnatal day 1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C0443281:Postnatal [Temporal Concept]
   726   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.44: Cortical tissue was then dissected and dissociated individually from each pup with the papain dissociation system (Worthington Biochemical Corp.). 

Phrase: "Cortical tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "and"

Phrase: "dissociated"

Phrase: "individually from each pup"

Phrase: "with the papain dissociation system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Worthington Biochemical Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.45: Cortical neurons were maintained in neurobasal medium (Invitrogen) supplemented with 1% B-27, 5% fetal calf serum, 0.5 mM glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin and grown on 3 g/ml laminin (Sigma) and 10 g/ml poly-L-lysine-coated cover plates. 

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "maintained in neurobasal medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C0024501:Maintain [Activity]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "supplemented with 1% B-27,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "5% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "0.5 mM glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "100 units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100 mg/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "grown on 3 g/ml laminin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "10 g/ml poly-L-lysine-coated cover plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   791   C1139930:plates [Medical Device]
   758 E C0005971:Plate [Medical Device]
   758 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.46: The cells were incubated in 95% air, 5% CO2 in a humidified incubator at 37 C. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in 95% air,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001861:Air [Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5% CO2 in a humidified incubator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "at 37 C."
Processing 00000000.tx.47: ImmunofluorescenceAfter treatments, cell cultures were fixed with phosphate-buffered saline (PBS) containing paraformaldehyde (4%) for 30 min. 

Phrase: "ImmunofluorescenceAfter treatments,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "fixed with phosphate-buffered saline (PBS) containing paraformaldehyde"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   748   C0231441:Fixed [Finding]
   748   C0332256:Containing [Functional Concept]
   748   C0443218:Fixed [Qualitative Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C2700400:Containing [Activity]
   748   C2827483:Fixed [Body Substance]

Phrase: "(4%"

Phrase: ")"

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.48: After several washes with PBS, the cells were preincubated in PBS containing 0.1% Triton X-100 and 1% fetal calf serum for 30 min. 

Phrase: "After several washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "with PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "1% fetal calf serum for 30 min."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015965:Fetal [Embryonic Structure]
   748   C0229671:Serum [Body Substance]
   748   C0230445:Calf [Body Location or Region]
   748   C0521457:Fetal [Functional Concept]
   748   C1305418:Calf [Body Part, Organ, or Organ Component]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
Processing 00000000.tx.49: After a brief wash with PBS, they were incubated for 1 h with primary antibodies at the following dilutions: anti-SC35 (1/100), anti--galactosidase (1/1000), anti-GSK-3 (1/50), anti-PHF-1 (1/100), anti-GSK-3/(pY279/216) (1/200). 

Phrase: "After a brief wash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Wash [Activity]

Phrase: "with PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "they"

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at the following dilutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0079240:dilutions [Laboratory Procedure]
   827 E C1948037:Dilution [Functional Concept]

Phrase: ":"

Phrase: "anti-SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419992:SC35 [Gene or Genome]
   861   C3538863:SC35 [Gene or Genome]

Phrase: "(1/100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "anti"

Phrase: "--"

Phrase: "galactosidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "anti-GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1/50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "anti-PHF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "(1/100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "anti-GSK-3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(pY279/216"

Phrase: ")"

Phrase: "(1/200"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.50: Cultures were extensively washed and then incubated with the appropriate secondary antibody, conjugated either with fluorescein isothiocyanate or with TexasRed (Jackson Laboratories, West Grove, PA) for 45 min. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "extensively"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with the appropriate secondary antibody,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1548787:Appropriate [Qualitative Concept]

Phrase: "conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]

Phrase: "either with fluorescein isothiocyanate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0124209:Isothiocyanate [Organic Chemical]
   770   C0206359:isothiocyanate [Organic Chemical]

Phrase: "or with TexasRed"

Phrase: "(Jackson Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "West Grove,"

Phrase: "PA) for 45 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C3541314:PA [Idea or Concept]
Processing 00000000.tx.51: For some experiments, TexasRed-phalloidin (Molecular Probes) was included with the secondary antibody to visualize F-actin. 

Phrase: "For some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "TexasRed-phalloidin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031312:Phalloidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "included with the secondary antibody to"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   783   C0175668:Secondary to [Temporal Concept]
           Secondary
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0027627:secondary [Neoplastic Process]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0332257:included [Functional Concept]
   753   C3538986:INCLUDED [Gene or Genome]
   719 E C1552866:include [Idea or Concept]
   719 E C2700399:Include [Activity]

Phrase: "visualize"

Phrase: "F-actin."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1622186:F-actin [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]
Processing 00000000.tx.52: After washing, they were immediately mounted with Fluoromount. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "they"

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "mounted with Fluoromount."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]
Processing 00000000.tx.53: Immunofluorescence was performed using confocal scanning microscopy (Bio-Rad) coupled to a vertical microscopy Axioskop2 (Zeiss). 

Phrase: "Immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "confocal scanning microscopy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242841:confocal scanning microscopy [Laboratory Procedure]
   913   C0242842:Microscopy, Confocal [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   755 E C0205288:Microscopic [Qualitative Concept]

Phrase: "(Bio-Rad)"

Phrase: "coupled to a vertical microscopy Axioskop2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0205128:Vertical [Spatial Concept]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]

Phrase: "(Zeiss"

Phrase: ")."
Processing 00000000.tx.54: In Vitro Kinase AssaysTo immunoprecipitate SC35, 500 g of cerebral cortex was incubated with 5 g of mouse monoclonal anti-SC35 in immunoprecipitation lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.4 mM sodium orthovanadate, 0.4 mM phenylmethylsulfonyl fluoride, 1% Nonidet P-40) overnight at 4 C with gentle agitation. 

Phrase: "In Vitro Kinase AssaysTo immunoprecipitate SC35,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1419992:SC35 [Gene or Genome]
   799   C3538863:SC35 [Gene or Genome]

Phrase: "500 g of cerebral cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with 5 g of mouse monoclonal anti-SC35"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0439267:g% [Quantitative Concept]
   742   C0746619:monoclonal [Finding]
   742   C1419992:SC35 [Gene or Genome]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C3538863:SC35 [Gene or Genome]

Phrase: "in immunoprecipitation lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "10 mM Tris-HCl,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.4 mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0029366:Orthovanadate [Inorganic Chemical]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "0.4 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with gentle agitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085631:Agitation [Sign or Symptom]
Processing 00000000.tx.55: Extracts were incubated with 5 g of rabbit anti-mouse (Dako) for 2 h and then with 30 l of protein A-Sepharose (Sigma) for another additional 1 h at 4 C. 

Phrase: "Extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "incubated with 5 g of rabbit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0034493:Rabbit [Mammal]
   753   C0439267:g% [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "(Dako"

Phrase: ")"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then with 30 l of protein A-Sepharose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0075172:protein A-sepharose [Carbohydrate]
   770   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036681:Sepharose [Carbohydrate]
   744   C1883708:Then [Temporal Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "for another additional 1 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.56: The immobilized immune complex was washed twice with immunoprecipitation lysis buffer and then resuspended in kinase buffer (20 mM Tris-HCl, pH 7.5, 5 mM Mg2Cl, 1 mM dithiothreitol, 250 M ATP, 20 mM LiCl, and 1 M okadaic acid) to prephosphorylate with "cold" phosphate the sites phosphorylated by coimmunoprecipitated kinases different from GSK-3. 

Phrase: "The immobilized immune complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003313:Immune complex [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439662:Immune [Functional Concept]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with immunoprecipitation lysis buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0024348:Lysis [Pathologic Function]
   760   C1536403:lysis [Cell Function]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in kinase buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(20 mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "5 mM Mg2Cl,"

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "250 M ATP,"

Phrase: "20 mM LiCl,"

Phrase: "and"

Phrase: "1 M okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prephosphorylate with ""cold"" phosphate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   770   C0031701:phosphate [Organophosphorus Compound]
   770   C0234192:Cold [Physiologic Function]
   770   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "the sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "phosphorylated by coimmunoprecipitated kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "different from GSK-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705242:Different [Qualitative Concept]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.57: The sample was incubated at 30 C for 30 min with shaking and then passed over a G-25 sizing column to remove ATP and LiCl. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "incubated at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "with shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "passed over a G-25 sizing column to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0439267:g% [Quantitative Concept]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1706132:Column [Idea or Concept]
   744   C2828386:Passed [Finding]
   711   C0456389:size [Spatial Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "ATP"

Phrase: "and"

Phrase: "LiCl."
Processing 00000000.tx.58: Afterward, the sample was phosphorylated in the same kinase buffer but with 10 M ATP (1000 cpm/pmol of [-32P]ATP; Amersham Biosciences), and 0.1 g/l recombinant GSK-3 (Sigma). 

Phrase: "Afterward,"

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "phosphorylated in the same kinase buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0445247:Same [Qualitative Concept]

Phrase: "but with 10 M ATP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "(1000 cpm/pmol of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "; Amersham Biosciences"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.1 g/l recombinant GSK-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   854   C0010536:G-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   849   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: The samples were incubated for 15 min at 30 C, and Laemmli sample buffer was added to stop the reaction. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 30 C,"

Phrase: "and"

Phrase: "Laemmli sample buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0258024:Laemmli buffer [Organic Chemical]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1947925:Stop [Activity]
  1000   C2746065:Stop [Temporal Concept]

Phrase: "the reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.60: Samples were boiled for 5 min, and proteins were separated in 10% SDS-polyacrylamide gels. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "boiled for 5 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated in 10% SDS-polyacrylamide gels."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   719 E C1382104:Gel [Substance]
Processing 00000000.tx.61: The gels were vacuum-dried and autoradiographed. 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "vacuum-dried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]

Phrase: "and"

Phrase: "autoradiographed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.62: The phosphorylated bands were quantitated with a densitometer. 

Phrase: "The phosphorylated bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "quantitated with a densitometer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0180321:Densitometer [Medical Device]
   770   C1706216:Densitometer [Medical Device]
Processing 00000000.tx.63: A peptide corresponding to residues 180-197 of SC35 protein, SC35180-197 (RSRSRSRSRSRSPPPVSK), as well as a prephosphorylated form P-SC35180-197 (RSRSRSRSRS(P)RSPPPVS(P)K), were chemically synthesized by Neosystem S.A. 

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to residues 180-197 of SC35 protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1419992:SC35 [Gene or Genome]
   744   C3538863:SC35 [Gene or Genome]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "SC35180-197"

Phrase: "(RSRSRSRSRSRSPPPVSK"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "a prephosphorylated form P-SC35180-197"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0348078:Form [Qualitative Concept]
   804   C0376315:Form [Manufactured Object]
   804   C1522492:Form [Functional Concept]

Phrase: "(RSRSRSRSRS"

Phrase: "(P)RSPPPVS"

Phrase: "(P)K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "chemically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220806:Chemically [Chemical]

Phrase: "synthesized by Neosystem S.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883254:Synthesized [Activity]
Processing 00000000.tx.64: (Strasbourg, France). 

Phrase: "(Strasbourg,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.65: The phosphorylation assay was carried out in a final volume of 50 l at 37 C in 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM dithiothreitol, and 50 mM NaCl. 

Phrase: "The phosphorylation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a final volume of 50 l"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205088:Final [Temporal Concept]
   744   C0439787:Out [Spatial Concept]
   744   C0449468:*Volume [Quantitative Concept]
   744   C0849355:Out [Qualitative Concept]
   744   C1546485:Final [Idea or Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "at 37 C in 50 mM Tris-HCl,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "50 mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.66: Phosphorylation was initiated by 0.1 g/l recombinant GSK-3 and [-32P]ATP plus MgCl2 (50 M (1 Ci of assay medium) and 10 mM, respectively, final concentrations). 

Phrase: "Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "initiated by 0.1 g/l recombinant GSK-3"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   797   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772   C1415377:GLYCOGEN SYNTHASE 1 [Gene or Genome]
   756   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0439294:g l [Quantitative Concept]
   754   C0010536:G-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   738   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0439267:g% [Quantitative Concept]
   738   C1514798:recombinant [Organism]
   704   C1548602:Initiate [Idea or Concept]
   704   C1704686:Initiate [Functional Concept]

Phrase: "and [-"

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP plus MgCl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0004221:ATP-MgCl2 [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(50"

Phrase: "M ("

Phrase: "1 Ci of assay medium"

Phrase: ")"

Phrase: "and"

Phrase: "10 mM,"

Phrase: "respectively,"

Phrase: "final concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.67: SDS-PAGE sample buffer was added to stop the reaction, and samples were electrophoresed on a 15% SDS gel. 

Phrase: "SDS-PAGE sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1947925:Stop [Activity]
  1000   C2746065:Stop [Temporal Concept]

Phrase: "the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "electrophoresed on a 15% SDS gel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]
   719   C0013855:electrophorese [Laboratory Procedure]
Processing 00000000.tx.68: The gels were vacuum-dried and autoradiographed. 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "vacuum-dried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]

Phrase: "and"

Phrase: "autoradiographed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.69: The phosphorylated bands were quantitated with a densitometer. 

Phrase: "The phosphorylated bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "quantitated with a densitometer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0180321:Densitometer [Medical Device]
   770   C1706216:Densitometer [Medical Device]
Processing 00000000.tx.70: The difference between the kinase activity in the presence or absence of 20 mM LiCl was considered to be a measure of GSK-3 protein kinase activity. 

Phrase: "The difference between the kinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 20 mM LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a measure of GSK-3 protein kinase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0079809:Measure [Quantitative Concept]
   739   C0242485:Measure [Functional Concept]
Processing 00000000.tx.71: Reverse Transcription of RNA and Polymerase Chain Reaction (RTPCR)Exon 10 splicing was assayed by RT-PCR as reported previously (37). 

Phrase: "Reverse Transcription of RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0035380:Reverse Transcription [Genetic Function]
   770   C0040649:Transcription [Genetic Function]
   770   C1555029:Reverse [Idea or Concept]

Phrase: "and"

Phrase: "Polymerase Chain Reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(RTPCR)Exon 10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "was"

Phrase: "assayed by RT-PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.72: Total RNA from different primary cultures was prepared using the reagent TRIzol (Invitrogen) and following the supplier's protocol. 

Phrase: "Total RNA from different primary cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the reagent TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the supplier's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.73: Reverse transcription was performed using the First cDNA synthesis kit (Roche Applied Science) on 5 g of RNA with oligo(dT) primers. 

Phrase: "Reverse transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the First cDNA synthesis kit (Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   818   C0681834:Applied Science [Research Activity]
   795   C0036397:Science [Occupation or Discipline]
   795   C0185125:Applied [Health Care Activity]
   762 E C1632850:Apply [Functional Concept]
   762 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "on 5 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with oligo(dT) primers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0069417:oligo (dT) [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.74: PCR was performed with the oligonucleotides R1 (5'-GGCGAATTCGGATCCATGCCAGACCTGAAGAATG-3') and R2 (5'-GGCCTGCAGTTACTCGCGGAAGGTCAGCTTGTG-3'). 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed with the oligonucleotides R1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0884358:Performed [Functional Concept]
   760   C1335648:R1 [Gene or Genome]
   760   C1824685:R1 [Gene or Genome]
   760   C2697937:R1 [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(5'-GGCGAATTCGGATCCATGCCAGACCTGAAGAATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "R2"

Phrase: "(5'-GGCCTGCAGTTACTCGCGGAAGGTCAGCTTGTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.75: The amplifications were performed basically with the following protocol: 30 cycles of 94 C for 45 s, 55 C for 1 min, and 72 C for 1 min. 

Phrase: "The amplifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1517480:Amplification [Molecular Biology Research Technique]
   966   C1521871:Amplification [Phenomenon or Process]
   966   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "basically with the following protocol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0442711:Protocol [Intellectual Product]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C2348563:Protocol [Intellectual Product]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "30 cycles of 94 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1511572:Cycle [Temporal Concept]

Phrase: "for 45 s,"

Phrase: "55 C for 1 min,"

Phrase: "and"

Phrase: "72 C for 1 min."
Processing 00000000.tx.76: The PCR products were resolved on a 1.8% agarose gel and stained with ethidium bromide. 

Phrase: "The PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on a 1.8% agarose gel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1706746:Agarose Gel [Research Device]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "stained with ethidium bromide."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.77: Two populations of RNA (coding for tau proteins containing three or four tubulin-binding motifs) are detected. 

Phrase: "Two populations of RNA (coding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "for tau proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "or"

Phrase: "four tubulin-binding motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514562:Motif [Amino Acid Sequence]

Phrase: ")"

Phrase: "are"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.78: The exon 10- (tau 3R) and exon 10+ (tau 4R) products as amplified by RT-PCR are 301 and 401 bp, respectively. 

Phrase: "The exon 10-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(tau 3R"

Phrase: ")"

Phrase: "and"

Phrase: "exon 10+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(tau 4R"

Phrase: ")"

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "as"

Phrase: "amplified by RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "are"

Phrase: "301"

Phrase: "and"

Phrase: "401 bp,"

Phrase: "respectively."
Processing 00000000.tx.79: As a loading control, RT-PCR for hypoxanthine-guanine phosphoribosyltransferase was performed for each sample. 

Phrase: "As a loading control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "RT-PCR for hypoxanthine-guanine phosphoribosyltransferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed for each sample."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C0884358:Performed [Functional Concept]
   770   C2347026:Sample [Conceptual Entity]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.80: The used primers for murine hypoxanthine-guanine phosphoribosyltransferase were 5'-CCTGGTTAAGCAGTACAGCC-3' and 5'-TCAAGGGCATATCCAACAACA-3'. 

Phrase: "The used primers for murine hypoxanthine-guanine phosphoribosyltransferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "5'-CCTGGTTAAGCAGTACAGCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-TCAAGGGCATATCCAACAACA-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.81: The amplification protocol was: 20 cycles with denaturation for 15 s at 95 C, annealing for 30 s at 60 C, and elongation for 1 min at 72 C. 

Phrase: "The amplification protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: ":"

Phrase: "20 cycles with denaturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 15 s"

Phrase: "at 95 C,"

Phrase: "annealing for 30 s"

Phrase: "at 60 C,"

Phrase: "and"

Phrase: "elongation for 1 min"

Phrase: "at 72 C."
Processing 00000000.tx.82: Differences among groups were analyzed by Student's unpaired t test to determine significant differences between means.  

Phrase: "Differences among groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed by Student's unpaired t test to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C1710574:Unpaired t-Test [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0038492:student [Professional or Occupational Group]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0936012:Analyzed [Research Activity]
   748   C1551041:student [Idea or Concept]
   748   C1552573:student [Intellectual Product]
   748   C2700112:Unpaired [Qualitative Concept]

Phrase: "determine"

Phrase: "significant differences between means."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.83: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  GSK-3 Inhibition Results in Decreased Tau Exon 10 Alternative Splicing in Cortical NeuronsAlternative splicing of exon 10 was investigated in cultured cortical neurons. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "GSK-3 Inhibition Results in Decreased Tau Exon 10 Alternative Splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   702   C1274040:Result [Functional Concept]
   702   C1546471:Result [Idea or Concept]
   702   C2825142:Result [Finding]

Phrase: "in Cortical NeuronsAlternative splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "of exon 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "investigated in cultured cortical neurons."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   760   C1292732:investigated [Functional Concept]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]
Processing 00000000.tx.84: Similar to early postnatal brain development, there is a progression in the expression from 3R tau expression to both 4R tau and 3R tau in cortical cultured neurons (Fig. 1A). 

Phrase: "Similar to early postnatal brain development,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "there"

Phrase: "is"

Phrase: "a progression in the expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]

Phrase: "from 3R tau expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "to both 4R tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "3R tau in cortical cultured neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.85: At the first day in vitro (DIV1), almost all the tau mRNA detected by RT-PCR (96  3%) is exclusively the isoform 3R-tau (Fig. 1, A and B). 

Phrase: "At the first day in vitro (DIV1),"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0332173:/day [Temporal Concept]
   812   C0439228:day [Temporal Concept]
   812   C0439505:/day [Temporal Concept]

Phrase: "almost"

Phrase: "all the tau mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "detected by RT-PCR (96  3%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0442726:Detected [Finding]
   753   C0677874:pCR [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "is"

Phrase: "exclusively"

Phrase: "the isoform 3R-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.86: At DIV3, a change in tau mRNA splicing takes place, and 4R isoforms can be detected by RT-PCR. 

Phrase: "At DIV3,"

Phrase: "a change in tau mRNA splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "4R isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "can"

Phrase: "be"

Phrase: "detected by RT-PCR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0442726:Detected [Finding]
   770   C0677874:pCR [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.87: More precisely, at DIV3, exon 10 is present in 15.9  1.5% of total tau-RNA (Fig. 1, A and B). 

Phrase: "More precisely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "at DIV3,"

Phrase: "exon 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "present in 15.9  1.5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "of total tau-RNA (Fig. 1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0250875:tau-1 [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0349966:Fig [Food]
   804   C0439175:% total [Quantitative Concept]
   804   C0439810:Total [Qualitative Concept]
   804   C1337208:FIG [Food]
   804   C1720655:Tau [Intellectual Product]
   804   C1947974:Tau [Research Activity]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.88: These studies demonstrate that the mechanism for the developmental regulation of the splicing of tau exon 10 is also present in cultured cortical neurons. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the mechanism for the developmental regulation of the splicing of tau exon 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0441712:Mechanism [Functional Concept]
   735   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "also"

Phrase: "present in cultured cortical neurons."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]
Processing 00000000.tx.89: We next studied the effect of incubation of neurons with the GSK-3 inhibitors lithium (35, 38) and AR-A014418 (AR-18) (39) on the 3R and 4R proportion of tau isoforms. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of incubation of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "with the GSK-3 inhibitors lithium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(35,"

Phrase: "38"

Phrase: ")"

Phrase: "and"

Phrase: "AR-A014418 (AR-18)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1432891:AR A014418 [Organic Chemical]

Phrase: "(39"

Phrase: ")"

Phrase: "on the 3R"

Phrase: "and"

Phrase: "4R proportion of tau isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]
Processing 00000000.tx.90: We first verified that 20 mM LiCl in the culture medium efficiently inhibited GSK-3 in the primary cultures. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "that 20 mM LiCl in the culture medium efficiently"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "GSK-3 in the primary cultures."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.91: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.92: 1, C and D, tau phosphorylation at the GSK-3-dependent epitope recognized by antibody PHF-1 (40, 41) was reduced to background levels. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "tau phosphorylation at the GSK-3-dependent epitope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "recognized by antibody PHF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: "was"

Phrase: "reduced to background levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0392756:Reduced [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1706907:Background [Conceptual Entity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.93: Lithium treatment was done in the presence of 10 mM myo-inositol to avoid any effect of the inositol depletion caused by inositol monophosphatase inhibition (35). 

Phrase: "Lithium treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "done in the presence of 10 mM myo-inositol to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021547:Myo-inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
           Inositol
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1272695:Done [Qualitative Concept]
   739   C2746065:Done [Temporal Concept]

Phrase: "avoid"

Phrase: "any effect of the inositol depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "caused by inositol monophosphatase inhibition"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0163342:inositol monophosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.94: The same analysis was carried out with 33 M AR-18, a concentration that inhibits tau phosphorylation in tau transfected cells (39). 

Phrase: "The same analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with 33 M AR-18,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439787:Out [Spatial Concept]
   760   C0441923:M+ [Intellectual Product]
   760   C0849355:Out [Qualitative Concept]

Phrase: "a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "that"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "tau phosphorylation in tau transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.95: We then analyzed whether the inhibition of GSK-3 by lithium and AR-18 treatments affects the expression of tau exon 10 at different culture times. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "whether"

Phrase: "the inhibition of GSK-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "AR-18 treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the expression of tau exon 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at different culture times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.96: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.97: 1, A and B, RT-PCR analysis on RNA isolated from control-, lithium-, and AR-18-treated cultures showed that GSK-3 inhibition resulted in increased proportion of 4R isoforms. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "RT-PCR analysis on RNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0200931:PCR analysis [Laboratory Procedure]
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   797   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "isolated from control-,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0205409:Isolated [Functional Concept]
   790   C0243148:control [Qualitative Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "lithium-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "AR-18-treated cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that GSK-3 inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resulted in increased proportion of 4R isoforms."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   748   C1709707:Proportion [Quantitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]
Processing 00000000.tx.98: These data demonstrate that alternative splicing of exon 10 is regulated by GSK-3. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that alternative splicing of exon 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002345:Alternative Splicing [Genetic Function]
   753   C0035687:Splicing [Genetic Function]
   753   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "regulated by GSK-3."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.99: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.100: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.101: Analysis of tau exon 10 alternative splicing by RT-PCR. 

Phrase: "Analysis of tau exon 10 alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "by RT-PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
Processing 00000000.tx.102: As shown in A, total RNA from cultured cortical neurons at DIV1 and -3 was prepared. 

Phrase: "As"

Phrase: "shown in A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "total RNA from cultured cortical neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at DIV1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: "and -"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "was"

Phrase: "prepared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.103: Vehicle, lithium chloride (20 mM), or AR-18 (33 M) was added 12 h before RNA extraction. 

Phrase: "Vehicle,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "lithium chloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(20 mM"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "AR-18"

Phrase: "(33"

Phrase: "M)"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "12 h before RNA extraction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.104: RT-PCR was between tau exon 9 and exon 11 (exon 10+ products are 401 bp, and exon 10- products are 301 bp). 

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was between tau exon 9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "exon 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exon 10+ products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "are"

Phrase: "401 bp,"

Phrase: "and"

Phrase: "exon 10- products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "are"

Phrase: "301 bp"

Phrase: ")."
Processing 00000000.tx.105: A representative gel is shown. 

Phrase: "A representative gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.106: RT-PCR for murine hypoxanthineguanine phosphoribosyltransferase (HPRT) amplification is shown as a loading control (bottom panel). 

Phrase: "RT-PCR for murine hypoxanthineguanine phosphoribosyltransferase (HPRT) amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]

Phrase: "is"

Phrase: "shown as a loading control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1708715:Loading [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C1547282:Show [Intellectual Product]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.107: B, quantization of tau exon 10 inclusion. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantization of tau exon 10 inclusion."
Processing 00000000.tx.108: Each bar represents the mean of at least three separate experiments being 100% the sum of both bands (tau exon 10- and tau exon 10+). 

Phrase: "Each bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "at least three separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "being"

Phrase: "100%"

Phrase: "the sum of both bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515051:Sum [Quantitative Concept]

Phrase: "(tau exon 10-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "tau exon 10+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: ")."
Processing 00000000.tx.109: Errors bars indicate standard deviations. 

Phrase: "Errors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0743559:errors [Qualitative Concept]
   966 E C1608199:Error [Functional Concept]

Phrase: "bars"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "standard deviations."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0871420:Standard deviation [Quantitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827   C0012727:Deviation [Spatial Concept]
   827   C0205419:Deviation [Qualitative Concept]
   827   C1705236:Deviation [Finding]
Processing 00000000.tx.110: *, value significantly different (p < 0.05) from those non-treated. 

Phrase: "*,"

Phrase: "value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "from those non-treated."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   916   C0679860:nontreatment [Health Care Activity]
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1518422:Non [Functional Concept]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.111: CON, control. 

Phrase: "CON,"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.112: C, confocal micrograph showing cortical neurons maintained in culture for 3 days that were double-labeled with a monoclonal antibody against phospho-tau (PHF-1, green) and TexasRed-phalloidin (red). 

Phrase: "C,"

Phrase: "confocal micrograph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   761   C0240341:Micrographia [Finding]
   761   C0596928:micrography [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "maintained in culture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1314677:Maintained [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C0024501:Maintain [Activity]

Phrase: "for 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "that"

Phrase: "were"

Phrase: "double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "labeled with a monoclonal antibody"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "against phospho-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(PHF-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "TexasRed-phalloidin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031312:Phalloidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.113: D, effect of lithium (20 mM) on PHF-1 IR. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "effect of lithium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "(20 mM) on PHF-1 IR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C1418486:MM-1 [Gene or Genome]
Processing 00000000.tx.114: E, effect of AR-18 (33 M). 

Phrase: "E,"

Phrase: "effect of AR-18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "(33"

Phrase: "M)."
Processing 00000000.tx.115: Neurons were incubated for 12 h with the inhibitor. 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated for 12 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with the inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.116: Cortical neurons were fixed and processed for immunofluorescence as described under "Experimental Procedures." 

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "processed for immunofluorescence"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0016318:Immunofluorescence [Laboratory Procedure]
   790   C0079603:Immunofluorescence [Laboratory Procedure]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]
   734 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   718 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.117: Bar, 50 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.118: The Nuclear Distribution of SC35 Is Sensitive to GSK-3 ActivityPre-mRNA splicing is catalyzed by a multimolecular complex including members of the SR family of splicing factors. 

Phrase: "The Nuclear Distribution of SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "Is"

Phrase: "Sensitive to GSK-3 ActivityPre-mRNA splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332324:Sensitive to [Functional Concept]
           Sensitive
   742   C1550474:sensitive [Idea or Concept]

Phrase: "is"

Phrase: "catalyzed by a multimolecular complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "members of the SR family of splicing factors."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.119: These splicing factors usually concentrate in nuclear speckles. 

Phrase: "These splicing factors usually"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "concentrate in nuclear speckles."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1750270:nuclear speckles [Cell Component]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1880310:Concentrate [Manufactured Object]
   770   C2003864:Concentrate [Substance]
Processing 00000000.tx.120: Taking into account that one of the two exon splicing enhancers present within tau exon 10 consists of a potential SC35-binding element (22) and that GSK-3 activity affects tau pre-mRNA splicing, we analyzed the effects of GSK-3 inhibition on the subcellular localization of SC35. 

Phrase: "Taking into"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "that one of the two exon splicing enhancers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "present within tau exon 10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "consists of a potential SC35-binding element"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C2986841:Binding Potential [Phenomenon or Process]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0243122:binding [Functional Concept]
   748   C0332529:CONSIST [Qualitative Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1419992:SC35 [Gene or Genome]
   748   C1705248:Element [Conceptual Entity]
   748   C3245505:Potential [Qualitative Concept]
   748   C3538863:SC35 [Gene or Genome]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "that GSK-3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "tau pre-mRNA splicing,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1622990:pre-mRNA splicing [Genetic Function]
   861   C0086934:mRNA splicing [Genetic Function]
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the effects of GSK-3 inhibition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on the subcellular localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "of SC35."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]
Processing 00000000.tx.121: Cortical neurons in culture (DIV3) displayed a diffuse predominantly nucleoplasmic staining pattern for SC35 (Fig. 2A) as evidenced by confocal microscopy analysis. 

Phrase: "Cortical neurons in culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "(DIV3"

Phrase: ")"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a diffuse predominantly nucleoplasmic staining pattern for SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1333299:Diffuse Pattern [Finding]
   744   C0449774:Pattern [Spatial Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "as"

Phrase: "evidenced by confocal microscopy analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0242842:Microscopy, Confocal [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.122: However, after GSK-3 inhibition with lithium, SC35 accumulates in nuclear speckles (Fig. 2B). 

Phrase: "However,"

Phrase: "after"

Phrase: "GSK-3 inhibition with lithium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "accumulates in nuclear speckles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1750270:nuclear speckles [Cell Component]
   770   C0521447:Nuclear [Spatial Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.123: A similar effect was observed with the more selective GSK-3 inhibitor AR-18 (Fig. 2C). 

Phrase: "A similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed with the more selective GSK-3 inhibitor AR-18"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   754   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   754   C3537023:kinase inhibitor [Molecular Function]
   754   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   738   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1441672:Observed [Functional Concept]
   738   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.124: View larger version (13K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.125: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.126: SC35 nuclear localization. 

Phrase: "SC35 nuclear localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]
Processing 00000000.tx.127: Cortical neurons were incubated for 12 h in the absence (A and D) or presence of 10 mM LiCl (B and E) or 33 M AR-18 (C and F). 

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated for 12 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(A"

Phrase: "and"

Phrase: "D)"

Phrase: "or"

Phrase: "presence of 10 mM LiCl (B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "E)"

Phrase: "or"

Phrase: "33 M AR-18"

Phrase: "(C"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.128: Cultures were fixed at DIV3. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "fixed at DIV3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]
Processing 00000000.tx.129: The localization of SC35 was determined by indirect immunofluorescence with monoclonal antibody SC35 and fluorescein isothiocyanate-conjugated secondary antibody (green, A-C). 

Phrase: "The localization of SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "determined by indirect immunofluorescence"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0282646:Indirect Immunofluorescence [Laboratory Procedure]
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   770   C0439852:Indirect [Qualitative Concept]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "with monoclonal antibody SC35"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1419992:SC35 [Gene or Genome]
   827   C3538863:SC35 [Gene or Genome]
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "fluorescein isothiocyanate-conjugated secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "A-C)."
Processing 00000000.tx.130: Actin was labeled with TexasRed-phalloidin (red, D-F). 

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "labeled with TexasRed-phalloidin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0031312:Phalloidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(red,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "D-"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.131: Neurons were fixed and processed for immunofluorescence as described under "Experimental Procedures." 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "processed for immunofluorescence"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0016318:Immunofluorescence [Laboratory Procedure]
   790   C0079603:Immunofluorescence [Laboratory Procedure]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]
   734 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   718 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.132: Bar, 20 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.133: SC35 Is Phosphorylated by GSK-3 in VitroThe effect of GSK-3 activity on SC35 localization raised the possibility that this SR protein might be a substrate for phosphorylation by GSK-3. 

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "Is"

Phrase: "Phosphorylated by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in VitroThe effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "of GSK-3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on SC35 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "this SR protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "a substrate for phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: "by GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.134: We therefore tested the ability of GSK-3 to phosphorylate SC35. 

Phrase: "We therefore"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the ability of GSK-3 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "phosphorylate"

Phrase: "SC35."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]
Processing 00000000.tx.135: SC35 was immunoprecipitated from brain homogenates (Fig. 3A), and the immunoprecipitate was incubated with recombinant GSK-3 in the presence or absence of lithium as well as AR-18. 

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated from brain homogenates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "was"

Phrase: "incubated with recombinant GSK-3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1514798:recombinant [Organism]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of lithium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "as well as"

Phrase: "AR-18."
Processing 00000000.tx.136: After resolving the samples on SDS-PAGE and exposing them to autoradiography, we observed a significant increase in32P incorporation in SC35 (about 2.5-fold over control; Fig. 3, B and C). 

Phrase: "After"

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "the samples on SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "exposing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:exposing [Clinical Attribute]

Phrase: "them to autoradiography,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004400:Autoradiography [Laboratory Procedure]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a significant increase in32P incorporation in SC35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]

Phrase: "(about 2.5-fold over control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "; Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.137: The radioactive incorporation was mediated by GSK-3 as it was inhibited by lithium chloride and the more selective inhibitor AR-18. 

Phrase: "The radioactive incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "mediated by GSK-3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "it"

Phrase: "was"

Phrase: "inhibited by lithium chloride"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "the more selective inhibitor AR-18."
Processing 00000000.tx.138: View larger version (28K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.140: GSK-3 phosphorylation of SC35 in an in vitro kinase assay. 

Phrase: "GSK-3 phosphorylation of SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "in an in vitro kinase assay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1515653:In Vitro Assay [Research Activity]
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.141: As shown in A, protein from total forebrain was incubated with (lane 1) or without (lane 2) mouse monoclonal anti-SC35 (dilution, 1/100). 

Phrase: "As"

Phrase: "shown in A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "protein from total forebrain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0439177:Protein.total [Quantitative Concept]
   819   C0555903:Total protein [Laboratory Procedure]
   819   C1261360:total protein [Laboratory or Test Result]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or without"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "mouse monoclonal anti-SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1419992:SC35 [Gene or Genome]
   812   C3538863:SC35 [Gene or Genome]

Phrase: "(dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "1/100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.142: ECL detection reagents (Amersham Biosciences) were used for immunodetection. 

Phrase: "ECL detection reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "were"

Phrase: "used for immunodetection."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.143: Immunoprecipitated samples were then resolved on a 10% SDS-polyacrylamide gel, transferred to a nitrocellulose membrane, and tested with monoclonal anti-SC35 (1/100) antibody. 

Phrase: "Immunoprecipitated samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resolved on a 10% SDS-polyacrylamide gel,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred to a nitrocellulose membrane,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "tested with monoclonal anti-SC35"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0392366:tested [Intellectual Product]
   760   C0746619:monoclonal [Finding]
   760   C1419992:SC35 [Gene or Genome]
   760   C3538863:SC35 [Gene or Genome]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "(1/100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.144: As shown in B, immunoprecipitated SC35 protein was incubated in the absence or presence of purified GSK-3 plus [-32P]ATP as described under "Experimental Procedures." 

Phrase: "As"

Phrase: "shown in B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "immunoprecipitated SC35 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of purified GSK-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.145: The assay was done in the absence or presence of GSK-3 inhibitors (20 mM LiCl or 33 M AR-18). 

Phrase: "The assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "done in the absence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C1272695:Done [Qualitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C2746065:Done [Temporal Concept]

Phrase: "or"

Phrase: "presence of GSK-3 inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(20 mM LiCl"

Phrase: "or"

Phrase: "33 M AR-18"

Phrase: ")."
Processing 00000000.tx.146: The samples were resolved on a 10% SDS-polyacrylamide gel and exposed to autoradiography. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "resolved on a 10% SDS-polyacrylamide gel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "exposed to autoradiography."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0004400:Autoradiography [Laboratory Procedure]
Processing 00000000.tx.147: C, quantitative data showing the increase in32P incorporation in immunoprecipitated SC35.  

Phrase: "C,"

Phrase: "quantitative data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the increase in32P incorporation in immunoprecipitated SC35."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.148: The motif (S/T)XXX(S/T) is a consensus site recognized by GSK-3, especially when it is phosphorylated in +4 S/T (42). 

Phrase: "The motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "("

Phrase: "S/"

Phrase: "T)XXX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442061:XXX [Laboratory Procedure]
   861   C1442442:XXX [Clinical Attribute]
   861   C1608330:XXX [Clinical Attribute]

Phrase: "("

Phrase: "S/"

Phrase: "T)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "is"

Phrase: "a consensus site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "recognized by GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "especially"

Phrase: "when"

Phrase: "it"

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "in +4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: "S/"

Phrase: "T (42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.149: Such a motif is present in tandem in the N-terminal site of SC35 (Fig. 4), suggesting that it is the region phosphorylated by GSK-3. 

Phrase: "Such"

Phrase: "a motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "present in tandem in the N-terminal site of SC35"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C2945843:Site of [Qualitative Concept]
   739   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   739   C0150312:Present [Quantitative Concept]
   739   C0205088:Terminal [Temporal Concept]
   739   C0205145:Site [Spatial Concept]
   739   C0449450:Present [Idea or Concept]
   739   C1419992:SC35 [Gene or Genome]
   739   C1515974:Site [Body Location or Region]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C2825164:Site [Spatial Concept]
   739   C3538863:SC35 [Gene or Genome]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "phosphorylated by GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.150: A peptide corresponding to predicted phosphorylation sequences was synthesized (Fig. 4A, residues 180-197). 

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to predicted phosphorylation sequences"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0681842:Predicted [Idea or Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1882327:%{Predicted} [Quantitative Concept]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "residues 180-197"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.151: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.152: 4, B and C, shows that unphosphorylated peptide is a poor substrate for the kinase. 

Phrase: "4,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that unphosphorylated peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "a poor substrate for the kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.153: However, when the same experimental protocol was carried out with primed peptide, a strong incorporation of radioactivity that was inhibited by lithium was observed (Fig. 4, B and C). 

Phrase: "However,"

Phrase: "when"

Phrase: "the same experimental protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with primed peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C0871133:primed [Functional Concept]

Phrase: "a strong incorporation of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "inhibited by lithium"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.154: In fact, the P-SC35180-197 peptide is a substrate for the kinase as good as GSM peptide, a peptide from glycogen synthase that is widely used to study GSK-3 activity (43). 

Phrase: "In fact,"

Phrase: "the P-SC35180-197 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "a substrate for the kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]

Phrase: "as good"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]

Phrase: "as GSM peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "a peptide from glycogen synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0030952:peptide synthase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "is"

Phrase: "widely"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "GSK-3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.155: The radioactivity incorporated in SR-18P peptide, in our experimental conditions, is 270  50 cpm nmol-1 min-1, whereas the radioactivity incorporated in GSM peptide is 340  35 cpm nmol-1 min-1. 

Phrase: "The radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "incorporated in SR-18P peptide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C1520795:18p [Nucleotide Sequence]
   760   C1553589:18p [Body Part, Organ, or Organ Component]

Phrase: "in our experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "is"

Phrase: "270  50 cpm nmol-1 min-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C2827910:nmol/min [Quantitative Concept]
   795   C0439191:NMOLE [Quantitative Concept]
   795   C0702093:/min [Temporal Concept]

Phrase: "whereas"

Phrase: "the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "incorporated in GSM peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C1300564:gsm [Quantitative Concept]

Phrase: "is"

Phrase: "340  35 cpm nmol-1 min-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C2827910:nmol/min [Quantitative Concept]
   795   C0439191:NMOLE [Quantitative Concept]
   795   C0702093:/min [Temporal Concept]
Processing 00000000.tx.156: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.157: 4. 

Phrase: "4."
Processing 00000000.tx.158: Domains and putative GSK-3 phosphorylation sites on SC35 protein. 

Phrase: "Domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "putative GSK-3 phosphorylation sites on SC35 protein."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0205145:Sites [Spatial Concept]
   726   C1519063:Phosphorylation Site [Amino Acid Sequence]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.159: Phosphorylation by GSK-3 is shown. 

Phrase: "Phosphorylation by GSK-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.160: A, gray box, Arg/Ser-rich (RS domain); 

Phrase: "A,"

Phrase: "gray box,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "Arg/Ser-rich (RS domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.161: shaded box, Gly-rich (Hinge region); 

Phrase: "shaded box,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "Gly-rich (Hinge region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0457406:Hinge [Medical Device]
   812   C1706053:Hinge [Medical Device]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.162: white box, RNA recognition motif. 

Phrase: "white box,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "RNA recognition motif."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1522002:RNA Recognition Motif [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3178797:RNA Motif [Nucleotide Sequence]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0524637:Recognition [Mental Process]
   827   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.163: Underlined amino acids are putative GSK-3 phosphorylation sites. 

Phrase: "Underlined"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "putative GSK-3 phosphorylation sites."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   795   C0031715:Phosphorylation [Molecular Function]
   795   C0205145:Sites [Spatial Concept]
   795   C1158886:Phosphorylation [Molecular Function]
   785   C1519063:Phosphorylation Site [Amino Acid Sequence]
   762 E C1515974:Site [Body Location or Region]
   762 E C2825164:Site [Spatial Concept]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.164: The SC35180-197 peptide is shown underline. 

Phrase: "The SC35180-197 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "underline."
Processing 00000000.tx.165: Data from Swiss Protein Database accession number for SC35 from Mus musculus Q62093 [GenBank] . As shown in B, GSK-3 phosphorylates a primed peptide (P-SC35180-197) to a significantly higher extent than unprimed peptide (SC35180-197). 

Phrase: "Data from Swiss Protein Database accession number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "for SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "from Mus musculus Q62093"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0025914:Mus musculus [Mammal]

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "] ."

Phrase: "As"

Phrase: "shown in B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylates"

Phrase: "a primed peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(P-SC35180-197"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "to a significantly higher extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439792:Extent [Spatial Concept]

Phrase: "than unprimed peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(SC35180-197"

Phrase: ")."
Processing 00000000.tx.166: As a control, GSK-3 was incubated with a substrate as well recognized as GSM peptide (43). 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "incubated with a substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1710236:Substrate [Manufactured Object]

Phrase: "as well recognized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "as GSM peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.167: The effect of 20 mM LiCl in the assay is shown. 

Phrase: "The effect of 20 mM LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.168: As shown in C, radioactivity incorporated in the P-SC35180-197 peptide was measured in the presence (filled symbol) and in the absence (open symbol) of lithium chloride as a function of incubation time.  

Phrase: "As"

Phrase: "shown in C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "incorporated in the P-SC35180-197 peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1099798:peptide P [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "measured in the presence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(filled symbol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0679214:symbol [Idea or Concept]
   861   C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "and in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(open symbol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0679214:symbol [Idea or Concept]
   861   C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "of lithium chloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of incubation time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.169: SC35 Colocalizes with GSK-3 to Speckled Regions in the NucleusTo determine whether a cross-talk occurs between SC35 and GSK-3 in cortical cultures, double immunolabeling experiments were performed with antibody SC35 and polyclonal GSK-3 antibody, which recognize active forms of GSK-3/ (GSK-3/(pY279/216)), in a confocal laser microscopy analysis. 

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "Colocalizes with GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "to Speckled Regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "in the NucleusTo"

Phrase: "determine"

Phrase: "whether"

Phrase: "a cross-talk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010357:Crosstalk [Molecular Function]
  1000   C2986468:Cross-talk [Cell Function]
   861   C0037817:Talk [Organism Function]
   861   C0234856:talk [Daily or Recreational Activity]
   861   C0600118:talk [Finding]
   861   C2828360:Cross [Conceptual Entity]

Phrase: "occurs between SC35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1419992:SC35 [Gene or Genome]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   790   C3538863:SC35 [Gene or Genome]

Phrase: "and"

Phrase: "GSK-3 in cortical cultures,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "double immunolabeling experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed with antibody SC35"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0884358:Performed [Functional Concept]
   770   C1419992:SC35 [Gene or Genome]
   770   C3538863:SC35 [Gene or Genome]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "polyclonal GSK-3 antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "recognize"

Phrase: "active forms of GSK-3/"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "(GSK-3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(pY279/216"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "in a confocal laser microscopy analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   708   C0242842:Microscopy, Confocal [Laboratory Procedure]
Processing 00000000.tx.170: In the absence of any treatment, fluorescence staining for GSK-3/(pY279/216) (Fig. 5A) was mainly cytoplasmatic, and within the nucleus, it was diffusely distributed. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of any treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "fluorescence staining for GSK-3/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "(pY279/216"

Phrase: ")"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "was"

Phrase: "mainly cytoplasmatic,"

Phrase: "and within the nucleus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C1515981:And [Idea or Concept]

Phrase: "it"

Phrase: "was"

Phrase: "diffusely"

Phrase: "distributed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]
Processing 00000000.tx.171: However, after lithium treatment, it was then redistributed to nuclear speckles (Fig. 5C) in colocalization with SC35 (Fig. 5D). 

Phrase: "However,"

Phrase: "after"

Phrase: "lithium treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "it"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "redistributed to nuclear speckles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1750270:nuclear speckles [Cell Component]
   770   C0521447:Nuclear [Spatial Concept]

Phrase: "(Fig. 5C"

Phrase: ")"

Phrase: "in colocalization"

Phrase: "with SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.172: These results indicate that GSK-3 inhibition enhances GSK-3 and SC35 co-localization in speckles. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that GSK-3 inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "SC35 co-localization in speckles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.173: View larger version (133K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(133K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.174: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.175: Active form of GSK-3 colocalizes with SC35 in speckled regions of the nucleus after lithium treatment. 

Phrase: "Active form of GSK-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "colocalizes with SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1419992:SC35 [Gene or Genome]
   790   C3538863:SC35 [Gene or Genome]

Phrase: "in speckled regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "after lithium treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.176: A confocal micrograph showing cortical neurons maintained in culture for 3 days and that were double labeled with a monoclonal antibody against GSK-3/(pY279/216) (A) and SC35 (B) is shown. 

Phrase: "A confocal micrograph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   761   C0240341:Micrographia [Finding]
   761   C0596928:micrography [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "maintained in culture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1314677:Maintained [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C0024501:Maintain [Activity]

Phrase: "for 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "that"

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "labeled with a monoclonal antibody"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "against GSK-3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(pY279/216"

Phrase: ")"

Phrase: "(A)"

Phrase: "and"

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "(B) is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.177: The effect of lithium (20 mM) on GSK-3/(pY279/216) (C) and SC35 (D) is also shown. 

Phrase: "The effect of lithium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(20 mM) on GSK-3/"

Phrase: "(pY279/216"

Phrase: ")"

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "("

Phrase: "D)"

Phrase: "is"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.178: Neurons were incubated for 12 h with the inhibitor. 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated for 12 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with the inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.179: Cortical neurons were fixed and processed for immunofluorescence as described under "Experimental Procedures." 

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "processed for immunofluorescence"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0016318:Immunofluorescence [Laboratory Procedure]
   790   C0079603:Immunofluorescence [Laboratory Procedure]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]
   734 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   718 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.180: Bar, 20 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.181: Arrows show speckled immunolabeling for GSK-3/(pY279/216) (C) and SC35 (D) after lithium treatment. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "speckled immunolabeling for GSK-3/"

Phrase: "(pY279/216"

Phrase: ")"

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "("

Phrase: "D)"

Phrase: "after"

Phrase: "lithium treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.182: Con, control.   

Phrase: "Con,"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.183: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The present results provide the first direct experimental evidence of the involvement of GSK-3 in tau mRNA splicing, thereby pointing to a novel role for GSK-3. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "experimental evidence of the involvement of GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in tau mRNA splicing,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086934:mRNA splicing [Genetic Function]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "thereby"

Phrase: "pointing to a novel role"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C2924612:Point A [Body Location or Region]
   760   C0035820:Role [Social Behavior]
   760   C0205314:Novel [Temporal Concept]
   760   C0679622:novel [Intellectual Product]
   760   C1705810:Role [Conceptual Entity]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]

Phrase: "for GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.184: Regarding the involved mechanism, we provide experimental data showing that GSK-3 phosphorylates SC35 and that GSK-3 activity affects SC35 localization in nuclear speckles. 

Phrase: "Regarding"

Phrase: "the involved mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "experimental data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylates"

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "and"

Phrase: "that GSK-3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "SC35 localization in nuclear speckles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.185: More precisely, we show that inhibition of GSK-3 results in increased exon 10+ tau transcription and increased nuclear localization of SC35 in speckles. 

Phrase: "More precisely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that inhibition of GSK-3 results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in increased exon 10+ tau transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "increased nuclear localization of SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in speckles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0439691:Speckled [Qualitative Concept]
Processing 00000000.tx.186: The exact molecular mechanism by which GSK-3 affects pre-mRNA splicing remains to be determined. 

Phrase: "The exact molecular mechanism by which GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "pre-mRNA splicing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1622990:pre-mRNA splicing [Genetic Function]
   901   C0086934:mRNA splicing [Genetic Function]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]
   734   C0026661:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.187: However, taking into account that (i) SR proteins are trans-acting factors that play an important role in splicing process through binding to splicing enhancers and mediating protein-protein interaction (44); 

Phrase: "However,"

Phrase: "taking into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "that"

Phrase: "(i) SR proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "trans-acting factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0040627:Trans-Acting Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2826298:TRANS [Idea or Concept]
   793   C0079613:ACT [Therapeutic or Preventive Procedure]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in splicing process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "through binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to splicing enhancers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "protein-protein interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704675:Interaction [Functional Concept]

Phrase: "(44"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.188: (ii) SR proteins are targeted to stores with the appearance of speckles through their RS domain (45, 46); 

Phrase: "(ii"

Phrase: ")"

Phrase: "SR proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "targeted to stores"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1521840:Targeted [Functional Concept]
   756   C1698986:Store [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "with the appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]

Phrase: "of speckles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0439691:Speckled [Qualitative Concept]

Phrase: "through their RS domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(45,"

Phrase: "46"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.189: and (iii) that they are released from them upon phosphorylation (47), the more likely hypothesis is that SC35 is released from speckles upon phosphorylation by GSK-3. 

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "released from them"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "upon phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "the more likely hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "that SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "is"

Phrase: "released from speckles"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]
   706   C0439691:Speckled [Qualitative Concept]

Phrase: "upon phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "by GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.190: However, SC35 phosphorylation by GSK-3 seems to require prephosphorylation by priming kinases. 

Phrase: "However,"

Phrase: "SC35 phosphorylation by GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "require"

Phrase: "prephosphorylation by priming kinases."
Processing 00000000.tx.191: Several protein kinases that regulate SR proteins could be possible candidates as priming kinases. 

Phrase: "Several protein kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "regulate"

Phrase: "SR proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "possible candidates as priming kinases."
Processing 00000000.tx.192: The SR protein kinase family and Clk kinase family are kinases that phosphorylate the RS domains of SR proteins (48). 

Phrase: "The SR protein kinase family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   741 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "Clk kinase family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
   734   C0084653:Clk kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "phosphorylate"

Phrase: "the RS domains of SR proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0162808:Protein Domains [Spatial Concept]
   750 E C1514562:Protein Domain [Amino Acid Sequence]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.193: Clk kinases are implicated in alternative splicing of human tau exon 10 (49). 

Phrase: "Clk kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0084653:Clk kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "implicated in alternative splicing of human tau exon 10"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0002345:Alternative Splicing [Genetic Function]
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0035687:Splicing [Genetic Function]
   742   C0086418:Human [Human]
   742   C1523987:Alternative [Conceptual Entity]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   742   C2610186:splicing [Genetic Function]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.194: We demonstrate the involvement of GSK-3 in SC35 distribution and alternative splicing of human tau exon 10. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "the involvement of GSK-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in SC35 distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "alternative splicing of human tau exon 10."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0002345:Alternative Splicing [Genetic Function]
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]
Processing 00000000.tx.195: Taking into account that GSK-3 phosphorylates immunoprecipitated SC35, the most likely explanation suggests a relationship among protein kinases that has been implicated in the phosphorylation of SR proteins and GSK-3. 

Phrase: "Taking into"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "that GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylates"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "SC35,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "the most likely explanation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0681841:Explanation [Intellectual Product]
   734   C0750501:most likely [Idea or Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a relationship among protein kinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the phosphorylation of SR proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.196: SR proteins released into the nucleoplasm are able to regulate alternative splicing by forming part of a multimolecular complex called the spliceosome, whose main components are small nuclear ribonucleoproteins, heteronuclear RNA-associated proteins, and SR proteins. 

Phrase: "SR proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "released into the nucleoplasm"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0391871:Released [Functional Concept]
   770   C0682537:Nucleoplasm [Cell Component]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "regulate"

Phrase: "alternative splicing by forming part of a multimolecular complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0002345:Alternative Splicing [Genetic Function]
   742   C0035687:Splicing [Genetic Function]
   742   C2610186:splicing [Genetic Function]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "the spliceosome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162771:spliceosome [Cell Component]
  1000   C2984264:Spliceosome [Functional Concept]

Phrase: "whose main components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "are"

Phrase: "small nuclear ribonucleoproteins,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0142661:Small Nuclear Ribonucleoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1167162:small nuclear ribonucleoprotein [Cell Component]
   827   C0035544:Ribonucleoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0700321:Small [Quantitative Concept]
   793 E C1167298:ribonucleoprotein [Cell Component]

Phrase: "heteronuclear RNA-associated proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "SR proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.197: If GSK-3 inhibition is occurring, SC35 and likely other SR proteins are concentrated in speckles, resulting in an inhibition of tau mRNA splicing. 

Phrase: "If"

Phrase: "GSK-3 inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "and"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "other SR proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "concentrated in speckles,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1880165:Concentrated [Biomedical or Dental Material]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]
   706   C0439691:Speckled [Qualitative Concept]

Phrase: "resulting in an inhibition of tau mRNA splicing."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C0086934:mRNA splicing [Genetic Function]
   770   C0332294:Resulting in [Functional Concept]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0035687:Splicing [Genetic Function]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0678226:resulting [Functional Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]
   744   C2610186:splicing [Genetic Function]
   744   C3463820:Inhibition [Activity]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]
Processing 00000000.tx.198: Our data raise the question regarding the physiological relevance of nuclear GSK-3. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "raise"

Phrase: "the question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "regarding"

Phrase: "the physiological relevance of nuclear GSK-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2347946:Relevance [Qualitative Concept]
Processing 00000000.tx.199: It has been described that nuclear GSK-3 is involved in phosphorylation of cyclin D1 (50), heat shock factor-1 (51-53), nuclear factor of activated T-cells (54), and cAMP-response element-binding protein (55). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "that nuclear GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "involved in phosphorylation of cyclin D1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1150565:cyclin [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1314939:Involved [Functional Concept]
   753   C1416886:D1 [Gene or Genome]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "heat shock factor-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1415749:HEAT-SHOCK FACTOR 1 [Gene or Genome]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0036974:Shock [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(51-53"

Phrase: ")"

Phrase: ","

Phrase: "nuclear factor of activated T-cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0288011:Nuclear Factor of Activated T-cells [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(54"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cAMP-response element-binding protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.200: In addition, proapoptotic stimuli induce nuclear accumulation of GSK-3 in SH-SY5Y (56, 57) and PC12 cells (57) as well as in vivo in neurons after ischemic insult (57). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "proapoptotic stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "nuclear accumulation of GSK-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0544910:Nuclear accumulation [Cell or Molecular Dysfunction]

Phrase: "in SH-SY5Y"

Phrase: "(56,"

Phrase: "57"

Phrase: ")"

Phrase: "and"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(57"

Phrase: ")"

Phrase: "as well as"

Phrase: "in vivo in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "after ischemic insult"

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.201: In this report, we demonstrate that GSK-3 colocalizes with SC35 in nuclear speckles after inhibition and is able to phosphorylate SC35 in vitro, demonstrating a novel role for the kinase in alternative splicing. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "colocalizes with SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1419992:SC35 [Gene or Genome]
   790   C3538863:SC35 [Gene or Genome]

Phrase: "in nuclear speckles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1750270:nuclear speckles [Cell Component]
   777   C0439691:Speckled [Qualitative Concept]

Phrase: "after inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "phosphorylate"

Phrase: "SC35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "demonstrating"

Phrase: "a novel role for the kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in alternative splicing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002345:Alternative Splicing [Genetic Function]
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
Processing 00000000.tx.202: The motif (S/T)XXX(S/T) is a consensus site recognized by GSK-3 (42). 

Phrase: "The motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "("

Phrase: "S/"

Phrase: "T)XXX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442061:XXX [Laboratory Procedure]
   861   C1442442:XXX [Clinical Attribute]
   861   C1608330:XXX [Clinical Attribute]

Phrase: "("

Phrase: "S/"

Phrase: "T)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "is"

Phrase: "a consensus site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "recognized by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.203: That motif is present in tandem in the N-terminal site of SC35 (Fig. 4), and we have here demonstrated that a peptide from that region is efficiently phosphorylated by the kinase but only when the peptide is phosphorylated, suggesting the requirement of a priming kinase. 

Phrase: "That motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "present in tandem in the N-terminal site of SC35"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C2945843:Site of [Qualitative Concept]
   739   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   739   C0150312:Present [Quantitative Concept]
   739   C0205088:Terminal [Temporal Concept]
   739   C0205145:Site [Spatial Concept]
   739   C0449450:Present [Idea or Concept]
   739   C1419992:SC35 [Gene or Genome]
   739   C1515974:Site [Body Location or Region]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C2825164:Site [Spatial Concept]
   739   C3538863:SC35 [Gene or Genome]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "here"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a peptide from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "efficiently"

Phrase: "phosphorylated by the kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "phosphorylated"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the requirement of a priming kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.204: Thus, this consensus motif must first be phosphorylated by a priming kinase at the Ser that is four amino acids C-terminal to the target site, which primes the substrate for phosphorylation by GSK-3. 

Phrase: "Thus,"

Phrase: "this consensus motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "must"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated by a priming kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0871133:Priming [Functional Concept]

Phrase: "at the Ser"

Phrase: "that"

Phrase: "is"

Phrase: "four amino acids C-terminal to the target site,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]
           C-Terminal
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: "which"

Phrase: "primes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "the substrate for phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: "by GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.205: The RS domain functions as a protein interaction domain. 

Phrase: "The RS domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "functions as a protein interaction domain."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   833   C1956034:Protein Interaction Domain [Spatial Concept]
   790   C0872079:protein interaction [Molecular Function]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0162808:Protein Domain [Spatial Concept]
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1514562:Protein Domain [Amino Acid Sequence]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1704675:Interaction [Functional Concept]
   753   C1705273:Function [Intellectual Product]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.206: The serines within the domain are phosphorylated, being as the subcellular localization of SR proteins is dependent of its phosphorylation status. 

Phrase: "The serines within the domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "are"

Phrase: "phosphorylated"

Phrase: ","

Phrase: "being as the subcellular localization of SR proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C0597704:protein localisation [Cell Function]
   750   C1159772:Protein Localization [Cell Function]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]
   744   C2987476:Being [Conceptual Entity]

Phrase: "is"

Phrase: "dependent of its phosphorylation status."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.207: The interaction with other proteins is also altered by phosphorylation. 

Phrase: "The interaction with other proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0872079:interaction protein [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "altered by phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0392747:Altered [Functional Concept]
   790   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.208: The DNA topoisomerase I and two families of kinases, the SR protein kinase (SRPK1 and -2), and the Clk/Sty family are involved in SR domain phosphorylation (for a review of SR proteins, see Ref. 44). 

Phrase: "The DNA topoisomerase I"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0012920:DNA Topoisomerase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNA Topoisomerase
           Topoisomerase I
  1000   C1458146:DNA Topoisomerase I [Amino Acid, Peptide, or Protein,Enzyme]
           Topoisomerase 1
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1336767:Topoisomerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2257142:topoisomerase [Genetic Function]

Phrase: "and"

Phrase: "two families of kinases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0015576:Families [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "the SR protein kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(SRPK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420412:SRPK1 [Gene or Genome]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Clk/Sty family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
   734   C1413489:CLK/STY [Gene or Genome]

Phrase: "are"

Phrase: "involved in SR domain phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1314939:Involved [Functional Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "("

Phrase: "for a review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "of SR proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 44"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.209: Our results implicate a new kinase, GSK-3, in SC35 phosphorylation and likely phosphorylation of other SR proteins. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "implicate"

Phrase: "a new kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in SC35 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "likely phosphorylation of other SR proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]
Processing 00000000.tx.210: The relevance of our data in relation to neurodegenerative diseases such as tauopathies can be a matter of debate, and the contribution of the tau isoforms for the development of neurodegeneration remains to be determined. 

Phrase: "The relevance of our data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "in relation to neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "such as tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "can"

Phrase: "be"

Phrase: "a matter of debate,"

Phrase: "and"

Phrase: "the contribution of the tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "for the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.211: This is important because data from FTDP-17 patients have demonstrated that the only tau mutations found in some of them have been those which affect the splicing of exon 10 and which increase the ratio of four-repeat with respect to three-repeat isoforms (58). 

Phrase: "This"

Phrase: "is"

Phrase: "important"

Phrase: "because"

Phrase: "data from FTDP-17 patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2707520:Patient data [Intellectual Product]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the only tau mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "found in some of them"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "those which"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the splicing of exon 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035687:Splicing [Genetic Function]
   760   C2610186:splicing [Genetic Function]

Phrase: "and"

Phrase: "which"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the ratio of four-repeat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "with respect to three-repeat isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.212: This is in contrast with Pick's disease in which tau isoforms are predominantly found with three repeats. 

Phrase: "This"

Phrase: "is in contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1979874:Contrast [Qualitative Concept]

Phrase: "with Pick's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0236642:Pick's Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1707391:Pick [Activity]
   861   C1826583:PICK [Gene or Genome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in which tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "predominantly"

Phrase: "found with three repeats."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0150312:Found [Quantitative Concept]
   770   C0205341:repeats [Functional Concept]
   770   C0205449:Three [Quantitative Concept]
   770   C1705914:Repeats [Conceptual Entity]
   737 E C0243095:Find [Finding]
   737 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.213: Therefore, an imbalance among tau isoforms and probably the type of neuron involved are relevant for the development of the illness. 

Phrase: "Therefore,"

Phrase: "an imbalance among tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1397014:Imbalance [Sign or Symptom]

Phrase: "and"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "the type of neuron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0682689:neuron type [Cell]
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "are"

Phrase: "relevant for the development of the illness."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.214: In any case, taking into account that the binding of tau to microtubules, as well as to cell membranes, is regulated by phosphorylation (59, 60) and that hypophosphorylated tau binds with high affinity to microtubules (whereas hyperphosphorylated tau, like that present in AD, shows a very low capacity to bind to microtubules (61, 62)), it is tempting to speculate that GSK-3 inhibition would favor the expression of tau 4R isoforms that are able to stabilize microtubules better than tau 3R isoforms (63). 

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "taking into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "that"

Phrase: "the binding of tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to microtubules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "as well as to cell membranes,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0007603:Cell membranes [Cell Component]
   756 E C3161472:Cell Membrane [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0025255:Membranes [Tissue]
   753   C0205170:Well [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3146287:Well [Manufactured Object]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "is"

Phrase: "regulated by phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "(59,"

Phrase: "60"

Phrase: ")"

Phrase: "and"

Phrase: "that hypophosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "binds with high affinity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205250:High [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1299351:High [Qualitative Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "("

Phrase: "whereas"

Phrase: "hyperphosphorylated tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "like that present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "in AD,"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a very low capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1516240:Capacity [Quantitative Concept]

Phrase: "bind to microtubules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026046:Microtubules [Cell Component]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "(61,"

Phrase: "62"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that GSK-3 inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "would"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the expression of tau 4R isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "better than tau 3R isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332272:Better [Qualitative Concept]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.215: In summary, GSK-3 is an enzyme that has been found at the convergence of pathways that are altered in AD and other tauopathies. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "found at the convergence of pathways"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0150312:Found [Quantitative Concept]
   753   C0443193:Convergence [Spatial Concept]
   753   C1446614:Convergence [Finding]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   753   C2700387:Convergence [Activity]
   719 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "are"

Phrase: "altered in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "other tauopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]
Processing 00000000.tx.216: GSK-3 has several roles in AD and tauopathies including tau hyperphosphorylation (32, 41, 64), modulation of presenilin (34, 65), and amyloid toxicity (34, 35). 

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "several roles in AD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "tau hyperphosphorylation"

Phrase: "(32,"

Phrase: "41,"

Phrase: "64"

Phrase: ")"

Phrase: ","

Phrase: "modulation of presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]

Phrase: "(34,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "amyloid toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.217: We have demonstrated here that GSK-3 modulates tau splicing, which is altered in some tauopathies, likely through SC35 protein, a member of the SR family of splicing factors.  

Phrase: "We"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "here"

Phrase: "that GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "tau splicing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "which"

Phrase: "is"

Phrase: "altered in some tauopathies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Altered [Functional Concept]
   770   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "likely through SC35 protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332148:Likely [Qualitative Concept]
   770   C0750492:Likely [Idea or Concept]
   770   C1419992:SC35 [Gene or Genome]
   770   C3538863:SC35 [Gene or Genome]

Phrase: "a member of the SR family of splicing factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.218: FOOTNOTES  * This work was supported by grants from Fundacin La Caixa, Comisin Interministerial de Ciencia y Tecnologa, Spain, and Comunidad de Madrid, Fundation Lilly, and by an institutional grant from Fundacin Ramn Areces. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from Fundacin La Caixa,"

Phrase: "Comisin Interministerial de Ciencia y Tecnologa,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "Comunidad de Madrid,"

Phrase: "Fundation Lilly,"

Phrase: "and by an institutional grant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018173:Grant [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1548284:Grant [Idea or Concept]

Phrase: "from Fundacin Ramn Areces."
Processing 00000000.tx.219: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.220: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.221: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.222: Present address: Departamento de Bioqumica y Biologa Molecular y Gentica, Universidad de Extremadura, 06071 Badajoz, Spain. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Departamento de Bioqumica y Biologa Molecular y Gentica,"

Phrase: "Universidad de Extremadura,"

Phrase: "06071 Badajoz,"

Phrase: "Spain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]
Processing 00000000.tx.223: || To whom correspondence should be addressed. 

Phrase: "||"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.224: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.225: 34-91-397-8443; 

Phrase: "34-91-397-8443"

Phrase: ";"
Processing 00000000.tx.226: Fax: 34-91-397-4799; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "34-91-397-4799"

Phrase: ";"
Processing 00000000.tx.227: Email: javila{at}cbm.uam.es . 1 The abbreviations used are: FTDP-17, frontotemporal dementia with parkinsonism associated to chromosome 17; 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "javila{at}cbm.uam.es . 1"

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "FTDP-17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: "frontotemporal dementia with parkinsonism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   909   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   833   C0236642:frontotemporal dementia [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "associated to chromosome 17"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   770   C0332281:Associated [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.228: GSK-3, glycogen synthase kinase; 

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.229: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.230: SR, serine/arginine-rich; 

Phrase: "SR,"

Phrase: "serine/arginine-rich"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0699759:Rich [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.231: RT, reverse transcription; 

Phrase: "RT,"

Phrase: "reverse transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.232: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.233: DIV, days in vitro.  

Phrase: "DIV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:div. [Functional Concept]

Phrase: "days in vitro."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.234: ACKNOWLEDGMENTS  We are grateful to Elena Langa and Raquel Cuadros for laboratory technical assistance.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Elena Langa"

Phrase: "and"

Phrase: "Raquel Cuadros for laboratory technical assistance."
Processing 00000000.tx.235: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Drubin, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Drubin,"

Phrase: "D."
Processing 00000000.tx.236: G., and Kirschner, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Kirschner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.237: W. 

Phrase: "W."
Processing 00000000.tx.238: (1986) J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.239: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.240: 103, 2739-2746[Abstract] Caceres, A., and Kosik, K. 

Phrase: "103,"

Phrase: "2739-2746"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Caceres,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.241: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.242: (1990) Nature 343, 461-463[CrossRef][Medline] [OrderarticleviaInfotrieve] Schoenfeld, T. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Nature 343,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "461-463"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schoenfeld,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.243: A., and Obar, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Obar,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.244: A. 

Phrase: "A."
Processing 00000000.tx.245: (1994) Int. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.246: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.247: Cytol. 

Phrase: "Cytol."
Processing 00000000.tx.248: 151, 67-137[Medline] [OrderarticleviaInfotrieve] Andreadis, A., Brown, W. 

Phrase: "151,"

Phrase: "67-137"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Andreadis,"

Phrase: "A.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "W."
Processing 00000000.tx.249: M., and Kosik, K. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.250: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.251: (1992) Biochemistry 31, 10626-10633[Medline] [OrderarticleviaInfotrieve] Goedert, M., Spillantini, M. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochemistry 31,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0450355:31 [Intellectual Product]

Phrase: "10626-10633"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.252: G., Jakes, R., Rutherford, D., and Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rutherford,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.253: A. 

Phrase: "A."
Processing 00000000.tx.254: (1989) Neuron 3, 519-526[Medline] [OrderarticleviaInfotrieve] Lovestone, S., and Reynolds, C. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Neuron 3,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "519-526"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Reynolds,"

Phrase: "C."
Processing 00000000.tx.255: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.256: (1997) Neuroscience 78, 309-324[CrossRef][Medline] [OrderarticleviaInfotrieve] Goedert, M., Spillantini, M. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuroscience 78,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "309-324"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: G., Hasegawa, M., Jakes, R., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.258: A., and Klug, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Klug,"

Phrase: "A."
Processing 00000000.tx.259: (1996) Cold Spring Harbor Symp. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cold Spring Harbor Symp."
Processing 00000000.tx.260: Quant. 

Phrase: "Quant."
Processing 00000000.tx.261: Biol. 

Phrase: "Biol."
Processing 00000000.tx.262: 61, 565-573[Medline] [OrderarticleviaInfotrieve] Goedert, M., and Spillantini, M. 

Phrase: "61,"

Phrase: "565-573"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.263: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.264: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.265: Soc. 

Phrase: "Soc."
Processing 00000000.tx.266: Symp. 

Phrase: "Symp."
Processing 00000000.tx.267: 59-71 Goedert, M., Spillantini, M. 

Phrase: "59-71 Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.268: G., Potier, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Potier,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.269: C., Ulrich, J., and Crowther, R. 

Phrase: "C., Ulrich,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.270: A. 

Phrase: "A."
Processing 00000000.tx.271: (1989) EMBO J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.272: 8, 393-399[Abstract] Lee, V. 

Phrase: "8,"

Phrase: "393-399"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lee,"

Phrase: "V."
Processing 00000000.tx.273: M., Goedert, M., and Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.274: Q. 

Phrase: "Q."
Processing 00000000.tx.275: (2001) Annu. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.276: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.277: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.278: 24, 1121-1159[CrossRef][Medline] [OrderarticleviaInfotrieve] Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P. 

Phrase: "24,"

Phrase: "1121-1159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Buee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bussiere,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Buee-Scherrer,"

Phrase: "V.,"

Phrase: "Delacourte,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Hof,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538150:HOF [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.279: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.280: (2000) Brain Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.281: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.282: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.283: 33, 95-130[Medline] [OrderarticleviaInfotrieve] Hutton, M., Lendon, C. 

Phrase: "33,"

Phrase: "95-130"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C."
Processing 00000000.tx.284: L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R. 

Phrase: "L., Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Isaacs,"

Phrase: "A.,"

Phrase: "Grover,"

Phrase: "A.,"

Phrase: "Hackett,"

Phrase: "J.,"

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Petersen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.285: C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J. 

Phrase: "C., Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551756:Stevens [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "de Graaff,"

Phrase: "E.,"

Phrase: "Wauters,"

Phrase: "E.,"

Phrase: "van Baren,"

Phrase: "J.,"

Phrase: "Hillebrand,"

Phrase: "M."

Phrase: ","

Phrase: "Joosse,"

Phrase: "M."

Phrase: ","

Phrase: "Kwon,"

Phrase: "J."
Processing 00000000.tx.286: M., Nowotny, P., Che, L. 

Phrase: "M."

Phrase: ","

Phrase: "Nowotny,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Che,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:CHE [Geographic Area]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.287: K., Norton, J., Morris, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Norton,"

Phrase: "J.,"

Phrase: "Morris,"

Phrase: "J."
Processing 00000000.tx.288: C., Reed, L. 

Phrase: "C., Reed,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.289: A., Trojanowski, J., Basun, H., Lannfelt, L., Neystat, M., Fahn, S., Dark, F., Tannenberg, T., Dodd, P. 

Phrase: "A.,"

Phrase: "Trojanowski,"

Phrase: "J.,"

Phrase: "Basun,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Neystat,"

Phrase: "M."

Phrase: ","

Phrase: "Fahn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823105:FAHN [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Dark,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tannenberg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dodd,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.290: R., Hayward, N., Kwok, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hayward,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kwok,"

Phrase: "J."
Processing 00000000.tx.291: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.292: J., Schofield, P. 

Phrase: "J.,"

Phrase: "Schofield,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.293: R., Andreadis, A., Snowden, J., Craufurd, D., Neary, D., Owen, F., Oostra, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Snowden,"

Phrase: "J.,"

Phrase: "Craufurd,"

Phrase: "D."

Phrase: ","

Phrase: "Neary,"

Phrase: "D."

Phrase: ","

Phrase: "Owen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Oostra,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.294: A., Hardy, J., Goate, A., Swieten, J. 

Phrase: "A.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Swieten,"

Phrase: "J."
Processing 00000000.tx.295: V., Mann, D., Lynch, T., and Heutink, P. 

Phrase: "V., Mann,"

Phrase: "D."

Phrase: ","

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.296: (1998) Nature 393, 702-705[CrossRef][Medline] [OrderarticleviaInfotrieve] Poorkaj, P., Bird, T. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 393,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "702-705"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.297: D., Wijsman, E., Nemens, E., Garruto, R. 

Phrase: "D."

Phrase: ","

Phrase: "Wijsman,"

Phrase: "E.,"

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Garruto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.298: M., Anderson, L., Andreadis, A., Wiederholt, W. 

Phrase: "M."

Phrase: ","

Phrase: "Anderson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Wiederholt,"

Phrase: "W."
Processing 00000000.tx.299: C., Raskind, M., and Schellenberg, G. 

Phrase: "C., Raskind,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.300: D. 

Phrase: "D."
Processing 00000000.tx.301: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.302: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.303: 43, 815-825[Medline] [OrderarticleviaInfotrieve] Spillantini, M. 

Phrase: "43,"

Phrase: "815-825"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.304: G., Murrell, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.305: R., Goedert, M., Farlow, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.306: R., Klug, A., and Ghetti, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Klug,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.307: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.308: Natl. 

Phrase: "Natl."
Processing 00000000.tx.309: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.310: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.311: U. 

Phrase: "U."
Processing 00000000.tx.312: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.313: A. 

Phrase: "A."
Processing 00000000.tx.314: 95, 7737-7741[Abstract/Free FullText] D'Souza, I., and Schellenberg, G. 

Phrase: "95,"

Phrase: "7737-7741"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "D'"

Phrase: "Souza,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.315: D. 

Phrase: "D."
Processing 00000000.tx.316: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.317: Biol. 

Phrase: "Biol."
Processing 00000000.tx.318: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.319: 275, 17700-17709[Abstract/Free FullText] Stanford, P. 

Phrase: "275,"

Phrase: "17700-17709"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stanford,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.320: M., Shepherd, C. 

Phrase: "M."

Phrase: ","

Phrase: "Shepherd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554210:Shepherd [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.321: E., Halliday, G. 

Phrase: "E.,"

Phrase: "Halliday,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.322: M., Brooks, W. 

Phrase: "M."

Phrase: ","

Phrase: "Brooks,"

Phrase: "W."
Processing 00000000.tx.323: S., Schofield, P. 

Phrase: "S."

Phrase: ","

Phrase: "Schofield,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.324: W., Brodaty, H., Martins, R. 

Phrase: "W., Brodaty,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.325: N., Kwok, J. 

Phrase: "N., Kwok,"

Phrase: "J."
Processing 00000000.tx.326: B., and Schofield, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Schofield,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.327: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.328: (2003) Brain 126, 814-826[Abstract/Free FullText] Hasegawa, M., Smith, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Brain 126,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "814-826"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.329: J., and Goedert, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.330: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.331: 437, 207-210[CrossRef][Medline] [OrderarticleviaInfotrieve] Clark, L. 

Phrase: "437,"

Phrase: "207-210"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Clark,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.332: N., Poorkaj, P., Wszolek, Z., Geschwind, D. 

Phrase: "N., Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Geschwind,"

Phrase: "D."
Processing 00000000.tx.333: H., Nasreddine, Z. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nasreddine,"

Phrase: "Z."
Processing 00000000.tx.334: S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K., Andreadis, A., D'Souza, I., Lee, V. 

Phrase: "S."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "D."

Phrase: ","

Phrase: "Payami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Awert,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Markopoulou,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "D'"

Phrase: "Souza,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.335: M., Reed, L., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Reed,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.336: Q., Zhukareva, V., Bird, T., Schellenberg, G., and Wilhelmsen, K. 

Phrase: "Q., Zhukareva,"

Phrase: "V.,"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wilhelmsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.337: C. 

Phrase: "C."
Processing 00000000.tx.338: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.339: Natl. 

Phrase: "Natl."
Processing 00000000.tx.340: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.341: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.342: U. 

Phrase: "U."
Processing 00000000.tx.343: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.344: A. 

Phrase: "A."
Processing 00000000.tx.345: 95, 13103-13107[Abstract/Free FullText] Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B. 

Phrase: "95,"

Phrase: "13103-13107"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Zhukareva,"

Phrase: "V.,"

Phrase: "Vogelsberg-Ragaglia,"

Phrase: "V.,"

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Reed,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.346: I., Geschwind, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Geschwind,"

Phrase: "D."
Processing 00000000.tx.347: H., Bird, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.348: D., McKeel, D., Goate, A., Morris, J. 

Phrase: "D."

Phrase: ","

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Morris,"

Phrase: "J."
Processing 00000000.tx.349: C., Wilhelmsen, K. 

Phrase: "C., Wilhelmsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.350: C., Schellenberg, G. 

Phrase: "C., Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.351: D., Trojanowski, J. 

Phrase: "D."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.352: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.353: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.354: (1998) Science 282, 1914-1917[Abstract/Free FullText] Varani, L., Hasegawa, M., Spillantini, M. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Science 282,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1914-1917"

Phrase: "[Abstract/Free FullText"

Phrase: "] Varani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: G., Smith, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.356: J., Murrell, J. 

Phrase: "J.,"

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.357: R., Ghetti, B., Klug, A., Goedert, M., and Varani, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Klug,"

Phrase: "A.,"

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Varani,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.358: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.359: Natl. 

Phrase: "Natl."
Processing 00000000.tx.360: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.361: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.362: U. 

Phrase: "U."
Processing 00000000.tx.363: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.364: A. 

Phrase: "A."
Processing 00000000.tx.365: 96, 8229-8234[Abstract/Free FullText] Rizzu, P., Van Swieten, J. 

Phrase: "96,"

Phrase: "8229-8234"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Swieten,"

Phrase: "J."
Processing 00000000.tx.366: C., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., Niermeijer, M. 

Phrase: "C., Joosse,"

Phrase: "M."

Phrase: ","

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Tibben,"

Phrase: "A.,"

Phrase: "Niermeijer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.367: F., Hillebrand, M., Ravid, R., Oostra, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hillebrand,"

Phrase: "M."

Phrase: ","

Phrase: "Ravid,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oostra,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.368: A., Goedert, M., van Duijn, C. 

Phrase: "A.,"

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "van Duijn,"

Phrase: "C."
Processing 00000000.tx.369: M., and Heutink, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.370: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: Hum. 

Phrase: "Hum."
Processing 00000000.tx.373: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.374: 64, 414-421[CrossRef][Medline] [OrderarticleviaInfotrieve] D'Souza, I., and Schellenberg, G. 

Phrase: "64,"

Phrase: "414-421"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "D'"

Phrase: "Souza,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.375: D. 

Phrase: "D."
Processing 00000000.tx.376: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.377: Biol. 

Phrase: "Biol."
Processing 00000000.tx.378: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.379: 277, 26587-26599[Abstract/Free FullText] Lamond, A. 

Phrase: "277,"

Phrase: "26587-26599"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lamond,"

Phrase: "A."
Processing 00000000.tx.380: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.381: (1991) Curr. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.382: Opin. 

Phrase: "Opin."
Processing 00000000.tx.383: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.384: 3, 493-501[Medline] [OrderarticleviaInfotrieve] Green, M. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "493-501"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.386: (1991) Annu. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.387: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.388: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.389: 7, 559-599[CrossRef][Medline] [OrderarticleviaInfotrieve] Fu, X. 

Phrase: "7,"

Phrase: "559-599"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "X."
Processing 00000000.tx.390: D., Mayeda, A., Maniatis, T., and Krainer, A. 

Phrase: "D."

Phrase: ","

Phrase: "Mayeda,"

Phrase: "A.,"

Phrase: "Maniatis,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Krainer,"

Phrase: "A."
Processing 00000000.tx.391: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.392: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.393: Natl. 

Phrase: "Natl."
Processing 00000000.tx.394: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.395: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.396: U. 

Phrase: "U."
Processing 00000000.tx.397: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.398: A. 

Phrase: "A."
Processing 00000000.tx.399: 89, 11224-11228[Abstract] Zahler, A. 

Phrase: "89,"

Phrase: "11224-11228"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zahler,"

Phrase: "A."
Processing 00000000.tx.400: M., Neugebauer, K. 

Phrase: "M."

Phrase: ","

Phrase: "Neugebauer,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.401: M., Lane, W. 

Phrase: "M."

Phrase: ","

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "W."
Processing 00000000.tx.402: S., and Roth, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Roth,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.404: (1993) Science 260, 219-222[Medline] [OrderarticleviaInfotrieve] Grimes, C. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 260,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "219-222"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grimes,"

Phrase: "C."
Processing 00000000.tx.405: A., and Jope, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.406: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.407: (2001) Prog. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.408: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.409: 65, 391-426[CrossRef][Medline] [OrderarticleviaInfotrieve] Woodgett, J. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "391-426"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Woodgett,"

Phrase: "J."
Processing 00000000.tx.410: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.411: (1990) EMBO J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.412: 9, 2431-2438[Abstract] Ferrer, I., Barrachina, M., and Puig, B. 

Phrase: "9,"

Phrase: "2431-2438"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ferrer,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Barrachina,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Puig,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.413: (2002) Acta Neuropathol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.414: (Berl.) 

Phrase: "(Berl."

Phrase: ")"
Processing 00000000.tx.415: 104, 583-591[Medline] [OrderarticleviaInfotrieve] Shiurba, R. 

Phrase: "104,"

Phrase: "583-591"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shiurba,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.416: A., Ishiguro, K., Takahashi, M., Sato, K., Spooner, E. 

Phrase: "A.,"

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "M."

Phrase: ","

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Spooner,"

Phrase: "E."
Processing 00000000.tx.417: T., Mercken, M., Yoshida, R., Wheelock, T. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Yoshida,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wheelock,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.418: R., Yanagawa, H., Imahori, K., and Nixon, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yanagawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Imahori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.419: A. 

Phrase: "A."
Processing 00000000.tx.420: (1996) Brain Res. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.421: 737, 119-132[CrossRef][Medline] [OrderarticleviaInfotrieve] Pei, J. 

Phrase: "737,"

Phrase: "119-132"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814202:PEI [Intellectual Product]
  1000   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "J."
Processing 00000000.tx.422: J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., and Cowburn, R. 

Phrase: "J.,"

Phrase: "Braak,"

Phrase: "E.,"

Phrase: "Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grundke-Iqbal,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Iqbal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Cowburn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.423: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.424: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.425: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.426: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.427: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.428: 58, 1010-1019[Medline] [OrderarticleviaInfotrieve] Lovestone, S., Reynolds, C. 

Phrase: "58,"

Phrase: "1010-1019"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "Reynolds,"

Phrase: "C."
Processing 00000000.tx.429: H., Latimer, D., Davis, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Latimer,"

Phrase: "D."

Phrase: ","

Phrase: "Davis,"

Phrase: "D."
Processing 00000000.tx.430: R., Anderton, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.431: H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gallo,"

Phrase: "J.-"

Phrase: "M."

Phrase: ","

Phrase: "Hanger,"

Phrase: "D."

Phrase: ","

Phrase: "Mulot,"

Phrase: "S."

Phrase: ","

Phrase: "Marquardt,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stabel,"

Phrase: "S."

Phrase: ","

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.432: R., and Miller, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.433: C. 

Phrase: "C."
Processing 00000000.tx.434: J. 

Phrase: "J."
Processing 00000000.tx.435: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.436: Biol. 

Phrase: "Biol."
Processing 00000000.tx.437: 4, 1077-1086[Medline] [OrderarticleviaInfotrieve] Lucas, J. 

Phrase: "4,"

Phrase: "1077-1086"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lucas,"

Phrase: "J."
Processing 00000000.tx.438: J., Hernandez, F., Gomez-Ramos, P., Moran, M. 

Phrase: "J.,"

Phrase: "Hernandez,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gomez-Ramos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Moran,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945650:moran [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.439: A., Hen, R., and Avila, J. 

Phrase: "A.,"

Phrase: "Hen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.440: (2001) EMBO J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.441: 20, 27-39[Abstract/Free FullText] Phiel, C. 

Phrase: "20,"

Phrase: "27-39"

Phrase: "[Abstract/Free FullText"

Phrase: "] Phiel,"

Phrase: "C."
Processing 00000000.tx.442: J., Wilson, C. 

Phrase: "J.,"

Phrase: "Wilson,"

Phrase: "C."
Processing 00000000.tx.443: A., Lee, V. 

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.444: M., and Klein, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Klein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.445: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.446: (2003) Nature 423, 435-439[CrossRef][Medline] [OrderarticleviaInfotrieve] Munoz-Montano, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nature 423,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "435-439"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Munoz-Montano,"

Phrase: "J."
Processing 00000000.tx.447: R., Moreno, F. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Moreno,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.448: J., Avila, J., and Diaz-Nido, J. 

Phrase: "J.,"

Phrase: "Avila,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Diaz-Nido,"

Phrase: "J."
Processing 00000000.tx.449: (1997) FEBS Lett. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.450: 411, 183-188[CrossRef][Medline] [OrderarticleviaInfotrieve] Martin-Aparicio, E., Yamamoto, A., Hernandez, F., Hen, R., Avila, J., and Lucas, J. 

Phrase: "411,"

Phrase: "183-188"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Martin-Aparicio,"

Phrase: "E.,"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "A.,"

Phrase: "Hernandez,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Avila,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Lucas,"

Phrase: "J."
Processing 00000000.tx.451: J. 

Phrase: "J."
Processing 00000000.tx.452: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.453: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.454: 21, 8772-8781[Abstract/Free FullText] Montejo de Garcini, E., Corrochano, L., Wischik, C. 

Phrase: "21,"

Phrase: "8772-8781"

Phrase: "[Abstract/Free FullText"

Phrase: "] Montejo de Garcini,"

Phrase: "E.,"

Phrase: "Corrochano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wischik,"

Phrase: "C."
Processing 00000000.tx.455: M., Diaz Nido, J., Correas, I., and Avila, J. 

Phrase: "M."

Phrase: ","

Phrase: "Diaz Nido,"

Phrase: "J.,"

Phrase: "Correas,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.456: (1992) FEBS Lett. 

Phrase: "(1992"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.457: 299, 10-14[CrossRef][Medline] [OrderarticleviaInfotrieve] Klein, P. 

Phrase: "299,"

Phrase: "10-14"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Klein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.458: S., and Melton, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Melton,"

Phrase: "D."
Processing 00000000.tx.459: A. 

Phrase: "A."
Processing 00000000.tx.460: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.461: Natl. 

Phrase: "Natl."
Processing 00000000.tx.462: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.463: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.464: U. 

Phrase: "U."
Processing 00000000.tx.465: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.466: A. 

Phrase: "A."
Processing 00000000.tx.467: 93, 8455-8459[Abstract/Free FullText] Bhat, R., Xue, Y., Berg, S., Hellberg, S., Orm, M., Nilsson, Y., Radester, A.-C., Jerning, E., Markgren, P.-O., Borgegrd, T., Nylf, M., Gimnez-Cassina, A., Hernndez, F., Lucas, J. 

Phrase: "93,"

Phrase: "8455-8459"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bhat,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xue,"

Phrase: "Y.,"

Phrase: "Berg,"

Phrase: "S."

Phrase: ","

Phrase: "Hellberg,"

Phrase: "S."

Phrase: ","

Phrase: "Orm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412647:ORM [Gene or Genome]
  1000   C1418186:ORM [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Nilsson,"

Phrase: "Y.,"

Phrase: "Radester,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1699468:radester [Organic Chemical]

Phrase: "A.-C.,"

Phrase: "Jerning,"

Phrase: "E.,"

Phrase: "Markgren,"

Phrase: "P.-O.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Borgegrd,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nylf,"

Phrase: "M."

Phrase: ","

Phrase: "Gimnez-Cassina,"

Phrase: "A.,"

Phrase: "Hernndez,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lucas,"

Phrase: "J."
Processing 00000000.tx.468: J., Daz-Nido, J., and Avila, J. 

Phrase: "J.,"

Phrase: "Daz-Nido,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.469: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.470: Biol. 

Phrase: "Biol."
Processing 00000000.tx.471: Chem., 278, 45937-45945[Abstract/Free FullText] Otvos, L., Jr., Feiner, L., Lang, E., Szendrei, G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "45937-45945"

Phrase: "[Abstract/Free FullText"

Phrase: "] Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Feiner,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lang,"

Phrase: "E.,"

Phrase: "Szendrei,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.472: I., Goedert, M., and Lee, V. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.473: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.474: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.475: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.476: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.477: 39, 669-673[Medline] [OrderarticleviaInfotrieve] Cho, J. 

Phrase: "39,"

Phrase: "669-673"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cho,"

Phrase: "J."
Processing 00000000.tx.478: H., and Johnson, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.479: V. 

Phrase: "V."
Processing 00000000.tx.480: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 278, 187-193[Abstract/Free FullText] Frame, S., Cohen, P., and Biondi, R. 

Phrase: "278,"

Phrase: "187-193"

Phrase: "[Abstract/Free FullText"

Phrase: "] Frame,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080089:Frame [Nucleotide Sequence]
  1000   C0180979:Frame [Medical Device]
  1000   C1705858:Frame [Manufactured Object]

Phrase: "S."

Phrase: ","

Phrase: "Cohen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Biondi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: (2001) Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.486: Cell 7, 1321-1327[CrossRef][Medline] [OrderarticleviaInfotrieve] Ryves, W. 

Phrase: "Cell 7,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1321-1327"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ryves,"

Phrase: "W."
Processing 00000000.tx.487: J., Fryer, L., Dale, T., and Harwood, A. 

Phrase: "J.,"

Phrase: "Fryer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dale,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Harwood,"

Phrase: "A."
Processing 00000000.tx.488: J. 

Phrase: "J."
Processing 00000000.tx.489: (1998) Anal. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.490: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.491: 264, 124-127[CrossRef][Medline] [OrderarticleviaInfotrieve] Graveley, B. 

Phrase: "264,"

Phrase: "124-127"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Graveley,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.492: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: (2000) RNA (N. Y.) 

Phrase: "(2000"

Phrase: ")"

Phrase: "RNA (N. Y."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1419492:RNA Y [Gene or Genome]

Phrase: ")"
Processing 00000000.tx.494: 6, 1197-1211 Hedley, M. 

Phrase: "6,"

Phrase: "1197-1211 Hedley,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.495: L., Amrein, H., and Maniatis, T. 

Phrase: "L., Amrein,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.496: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.497: Natl. 

Phrase: "Natl."
Processing 00000000.tx.498: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.499: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.500: U. 

Phrase: "U."
Processing 00000000.tx.501: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.502: A. 

Phrase: "A."
Processing 00000000.tx.503: 92, 11524-11528[Abstract] Misteli, T., Caceres, J. 

Phrase: "92,"

Phrase: "11524-11528"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Misteli,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Caceres,"

Phrase: "J."
Processing 00000000.tx.504: F., and Spector, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Spector,"

Phrase: "D."
Processing 00000000.tx.505: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.506: (1997) Nature 387, 523-527[CrossRef][Medline] [OrderarticleviaInfotrieve] Gui, J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 387,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "523-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gui,"

Phrase: "J."
Processing 00000000.tx.507: F., Lane, W. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "W."
Processing 00000000.tx.508: S., and Fu, X. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "X."
Processing 00000000.tx.509: D. 

Phrase: "D."
Processing 00000000.tx.510: (1994) Nature 369, 678-682[CrossRef][Medline] [OrderarticleviaInfotrieve] Misteli, T. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 369,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "678-682"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Misteli,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.511: (1999) Curr. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.512: Biol. 

Phrase: "Biol."
Processing 00000000.tx.513: 9, R198-200[CrossRef][Medline] [OrderarticleviaInfotrieve] Hartmann, A. 

Phrase: "9,"

Phrase: "R198-200"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hartmann,"

Phrase: "A."
Processing 00000000.tx.514: M., Rujescu, D., Giannakouros, T., Nikolakaki, E., Goedert, M., Mandelkow, E. 

Phrase: "M."

Phrase: ","

Phrase: "Rujescu,"

Phrase: "D."

Phrase: ","

Phrase: "Giannakouros,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nikolakaki,"

Phrase: "E.,"

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.515: M., Gao, Q. 

Phrase: "M."

Phrase: ","

Phrase: "Gao,"

Phrase: "Q."
Processing 00000000.tx.516: S., Andreadis, A., and Stamm, S. 

Phrase: "S."

Phrase: ","

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Stamm,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.517: (2001) Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.518: Cell Neurosci. 

Phrase: "Cell Neurosci."
Processing 00000000.tx.519: 18, 80-90[CrossRef][Medline] [OrderarticleviaInfotrieve] Diehl, J. 

Phrase: "18,"

Phrase: "80-90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Diehl,"

Phrase: "J."
Processing 00000000.tx.520: A., Cheng, M., Roussel, M. 

Phrase: "A.,"

Phrase: "Cheng,"

Phrase: "M."

Phrase: ","

Phrase: "Roussel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.521: F., and Sherr, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Sherr,"

Phrase: "C."
Processing 00000000.tx.522: J. 

Phrase: "J."
Processing 00000000.tx.523: (1998) Genes Dev. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.524: 12, 3499-3511[Abstract/Free FullText] He, B., Meng, Y. 

Phrase: "12,"

Phrase: "3499-3511"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "He,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Meng,"

Phrase: "Y."
Processing 00000000.tx.525: H., and Mivechi, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mivechi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.526: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.527: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.528: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.529: Biol. 

Phrase: "Biol."
Processing 00000000.tx.530: 18, 6624-6633[Abstract/Free FullText] Bijur, G. 

Phrase: "18,"

Phrase: "6624-6633"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bijur,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.531: N., and Jope, R. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.533: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.534: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.535: 75, 2401-2408[CrossRef][Medline] [OrderarticleviaInfotrieve] Xavier, I. 

Phrase: "75,"

Phrase: "2401-2408"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Xavier,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.536: J., Mercier, P. 

Phrase: "J.,"

Phrase: "Mercier,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.537: A., McLoughlin, C. 

Phrase: "A.,"

Phrase: "McLoughlin,"

Phrase: "C."
Processing 00000000.tx.538: M., Ali, A., Woodgett, J. 

Phrase: "M."

Phrase: ","

Phrase: "Ali,"

Phrase: "A.,"

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.539: R., and Ovsenek, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Ovsenek,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.540: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.541: Biol. 

Phrase: "Biol."
Processing 00000000.tx.542: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.543: 275, 29147-29152[Abstract/Free FullText] Beals, C. 

Phrase: "275,"

Phrase: "29147-29152"

Phrase: "[Abstract/Free FullText"

Phrase: "] Beals,"

Phrase: "C."
Processing 00000000.tx.544: R., Sheridan, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sheridan,"

Phrase: "C."
Processing 00000000.tx.545: M., Turck, C. 

Phrase: "M."

Phrase: ","

Phrase: "Turck,"

Phrase: "C."
Processing 00000000.tx.546: W., Gardner, P., and Crabtree, G. 

Phrase: "W., Gardner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Crabtree,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.547: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.548: (1997) Science 275, 1930-1934[Abstract/Free FullText] Bullock, B. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 275,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1930-1934"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bullock,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.549: P., and Habener, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Habener,"

Phrase: "J."
Processing 00000000.tx.550: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.551: (1998) Biochemistry 37, 3795-3809[CrossRef][Medline] [OrderarticleviaInfotrieve] Bijur, G. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "3795-3809"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bijur,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.552: N., and Jope, R. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.553: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.554: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.555: Biol. 

Phrase: "Biol."
Processing 00000000.tx.556: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.557: 276, 37436-37442[Abstract/Free FullText] Bhat, R. 

Phrase: "276,"

Phrase: "37436-37442"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bhat,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.558: V., Shanley, J., Correll, M. 

Phrase: "V., Shanley,"

Phrase: "J.,"

Phrase: "Correll,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.559: P., Fieles, W. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fieles,"

Phrase: "W."
Processing 00000000.tx.560: E., Keith, R. 

Phrase: "E.,"

Phrase: "Keith,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.561: A., Scott, C. 

Phrase: "A.,"

Phrase: "Scott,"

Phrase: "C."
Processing 00000000.tx.562: W., and Lee, C. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "C."
Processing 00000000.tx.563: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.564: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.565: Natl. 

Phrase: "Natl."
Processing 00000000.tx.566: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.567: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.568: U. 

Phrase: "U."
Processing 00000000.tx.569: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.570: A. 

Phrase: "A."
Processing 00000000.tx.571: 97, 11074-11079[Abstract/Free FullText] Heutink, P. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "11074-11079"

Phrase: "[Abstract/Free FullText"

Phrase: "] Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.572: (2000) Hum. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.573: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.574: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.575: 9, 979-986[Abstract/Free FullText] Lindwall, G., and Cole, R. 

Phrase: "9,"

Phrase: "979-986"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lindwall,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cole,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.576: D. 

Phrase: "D."
Processing 00000000.tx.577: (1984) J. 

Phrase: "(1984"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.578: Biol. 

Phrase: "Biol."
Processing 00000000.tx.579: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.580: 259, 5301-5305[Abstract/Free FullText] Arrasate, M., Perez, M., and Avila, J. 

Phrase: "259,"

Phrase: "5301-5305"

Phrase: "[Abstract/Free FullText"

Phrase: "] Arrasate,"

Phrase: "M."

Phrase: ","

Phrase: "Perez,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.581: (2000) Neurochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.582: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.583: 25, 43-50[CrossRef][Medline] [OrderarticleviaInfotrieve] Kosik, K. 

Phrase: "25,"

Phrase: "43-50"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.584: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.585: (1992) Science 256, 780-783[Medline] [OrderarticleviaInfotrieve] Garcia de Ancos, J., Correas, I., and Avila, J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 256,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "780-783"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Garcia de Ancos,"

Phrase: "J.,"

Phrase: "Correas,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.586: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.587: Biol. 

Phrase: "Biol."
Processing 00000000.tx.588: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.589: 268, 7976-7982[Abstract/Free FullText] Lu, M., and Kosik, K. 

Phrase: "268,"

Phrase: "7976-7982"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.590: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.591: (2001) Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.592: Biol. 

Phrase: "Biol."
Processing 00000000.tx.593: Cell 12, 171-184[Abstract/Free FullText] Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T., and Imahori, K. 

Phrase: "Cell 12,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "171-184"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shiratsuchi,"

Phrase: "A.,"

Phrase: "Sato,"

Phrase: "S."

Phrase: ","

Phrase: "Omori,"

Phrase: "A.,"

Phrase: "Arioka,"

Phrase: "M."

Phrase: ","

Phrase: "Kobayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Uchida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Imahori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.594: (1993) FEBS Lett. 

Phrase: "(1993"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.595: 325, 167-172[CrossRef][Medline] [OrderarticleviaInfotrieve] Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., and Wolozin, B. 

Phrase: "325,"

Phrase: "167-172"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Takashima,"

Phrase: "A.,"

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kohno,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sugihara,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.596: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.597: Natl. 

Phrase: "Natl."
Processing 00000000.tx.598: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.599: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.600: U. 

Phrase: "U."
Processing 00000000.tx.601: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.602: A. 

Phrase: "A."
Processing 00000000.tx.603: 95, 9637-9641[Abstract/Free FullText]

Phrase: "95,"

Phrase: "9637-9641"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

